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Summary
Copy Number Variation (CNV) is an important class of genetic variation, which
has been traditionally studied using microarray-based Comparative Genomic
Hybridization. Recently the next-generation sequencing technologies have
revolutionized biological research, especialy in this area.
We developed one of the first methods to detect CNV utilizing DNA se-
quencing, which we call CNV-seq. This method is based on a robust statistical
model that describes the complete analysis procedure and allows the com-
putation of essential confidence values for detection of CNV. The statistical
model also shows that the next-generation sequencing technologies are more
suitable for CNV-seq than traditional sequencing technologies.
Based on the statistical model of CNV-seq, we also developed a two-stage
Hidden Markov Model, CNV-segHMM for analyzing CNV-seq data. The res-
olution of CNV boundary detection by the HMM approach is the distance
between two adjacent mapped sequencing reads, which is the highest possible
resolution. By increasing the number of reads sequenced, single-nucleotide
resolution can be achieved. Together with the increasing speed and decreasing
cost of sequencing technologies, we expect our CNV-seq framework and the
CNV-segHMM tool to be widely used.
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1.1 Copy Number Variation
1.1.1 What is Copy Number Variation?
Every individual genome is different, including the genomes of identical twins
(Notini et al., 2008). Genomic variations have different forms, such as Single
Nucleotide Polymorphism (SNP) and short insertion or deletion (indel) (Shas-
try, 2009). Variations with size greater than several nucleotides form another
broad class of variations — structural genomic variation (Frazer et al., 2009).
One type of structural genomic variation is balanced DNA rearrangements,
1
1.1 COPY NUMBER VARIATION 2
such as translocation and inversion. All those variations have been under ex-
tensive study for a long time. However, a relatively new member of structural
variation attracts attention from researchers recently — DNA Copy Number
Variation (CNV) (Buckley et al., 2005; Freeman et al., 2006; Human Genome
Structural Variation Working Group et al., 2007; Henrichsen et al., 2009).
CNV is a class of variations where the copy number of a DNA segment is
varied between different genomes of the same species. When genes are located
in CNV regions, the dosage of genes are changed, which in turn may cause
phenotypic changes in an organism. Most CNVs are inherited from parents,
but can also arise from at meiotic and somatic level as suggested by CNVs
between identical twins and between different organ or tissues of the same
individual (Hastings et al., 2009).
In comparison with SNP, where a clear definition describes variation on
single nucleotide, CNV is not as clearly defined. For example, what are the
criteria for classifying two DNA segments as two copies of one? Or what size
of the segment should be considered as CNV? Earlier works usually defined
CNV as segments larger than 1 Mb (Iafrate et al., 2004), or larger than 50 Kb
(Redon et al., 2006), mainly due to technical difficulties for detecting small
CNV segments (McPherson, 2009; Medvedev et al., 2009). As technology de-
velops, detection of smaller CNV segments becomes possible. Some groups
define CNV as segments larger than 300 bases (Conrad et al., 2006), while some
groups define the lower bound of segment size as 100 bases (Zhang et al.,
2009). However, as the segment size becomes smaller, we have higher chance
of observing two random segments with similar sequence to each other, there-
fore hard to determine whether two similar segments are two copies of one
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segment or similar due to chance. One of the most commonly used criteria
for CNV is that only segments whose size are 1,000 bases or larger with 90%
and above sequence identity are classified as CNV (Cook and Scherer, 2008;
Hastings et al., 2009; Wain et al., 2009).
In addition, CNV does not include simple short repeats, which could be
longer than some of the above definitions. For example, long interspersed
repetitive elements (LINEs) are about 1 Kb long, while short interspersed repet-
itive elements (SINEs) are about 500 bases (Wain et al., 2009).
The possible mechanisms of change in gene copy number have been re-
viewed extensively by Hastings et al. (2009).
1.1.2 Brief History of CNV Discovery
Although the name CNV was only coined recently, the first well-known CNV
was discovered in 1936, before the discovery of the structure of DNA. — the du-
plication of a DNA segment containing the Bar gene in Drosophila melanogaster.
In 1936, Bridges discovered that the copy number of a chromosomal segment
determines the Bar eye phenotype in Drosophila melanogaster. Further study
identified the Bar gene in this segment on chromosome X. In a normal female
fruit fly, which has only one copy of Bar gene in each chromosome X, there are
about 810 facets in its eye. While in Bar homozygote fly, which has two copies
of the gene in each chromosome X, there are only about 70 facets in each eye.
When there are three copies of the gene, the ultra-bar phenotype will show up
— only 25 facets in each eye.
This early discovery was possible thanks to the giant polytene chromo-
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somes in D. melanogaster’s salivary glands, where the DNA is repeatedly repli-
cated without cell division and therefore the duplication or deletion of the chro-
mosomal segment that can be observed by conventional microscopy (Bridges,
1936). Similarly, whole chromosome copy number changes are easy to detect
by microscopy as well. An extra copy of chromosome 21 — the cause of the
well-known Down syndrome in human, was discovered in 1959 by Lejeune
et al.. However, most submicroscopic CNVs are not detected until 1990s.
In 1991, a duplication of 500 Kb DNA segment in chromosome 17 was
found to be associated with Charcot-Marie-tooth disease type 1A (CMT1A)
(Lupski et al., 1991, 1992). CMT1A is the most common peripheral neuropathy
in humans, where the nerves of peripheral nervous system are damaged, re-
sulting decreased nerve conduction velocities. In 1993, a large deletion of 1.5
Mb segment in chromosome 17, which covers the whole CMT1A duplication
region, was found to be associated with hereditary neuropathy with liability to
pressure palsies (HNPP) — another disease affecting peripheral nerves (Chance
et al., 1993).
A large-scale CNV discovery started a decade ago along with the finished
Human Genome Project and the development of various genomic technolo-
gies. In 2004, 221 CNVs were described by utilizing oligonucleotide microarray
analysis on 20 normal humans (Sebat et al., 2004). These CNV regions cover
70 genes with various functions including genes known to be associated with
disease. In another large-scale study, 225 CNVs were identified among 55 un-
related individuals. About 41% of these CNVs occurred in more than one and
9% in more than 10% of the studied individuals (Iafrate et al., 2004). In the
landmark study in 2006, Redon and colleagues found 1,447 CNV regions to
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cover 12% of the human genome, with no large stretches of the genome ex-
empt from CNV (Redon et al., 2006). The CNV regions cover more nucleotide
content per genome than single nucleotide polymorphisms, suggesting the
importance of CNV in genetic diversity (Redon et al., 2006). Large-scale studies
of CNV flourished, and CNVs reported in the current Database of Genomic
Variants (DGV) now cover 29.7% of the human genome (Zhang et al., 2009).
1.1.3 Human CNV and Health
A number of studies associates CNVs with human health have been conducted
(McCarroll, 2008; Conrad et al., 2009; Kato et al., 2009). The Database of Chro-
mosomal Imbalance and Phenotype in Humans using Ensembl Resources
(DECIPHER) have archived 58 syndromes associated with CNVs in 4,035 cases
till 2009 (Firth et al., 2009). The number of known associations is expected to
increase rapidly, as indicated by the increasing number of related publications
in PubMed (Figure 1.1).
The phenotypic impacts of CNVs vary depending on the genes covered by
the CNVs. Both beneficial and harmful CNVs to human health are reported.
However the reported harmful CNVs largely out-number beneficial ones (Hast-
ings et al., 2009; Henrichsen et al., 2009; Wain et al., 2009; Zhang et al., 2009).
Examples of associations in each category are described section 1.1.3.1 and
1.1.3.2.

















































Figure 1.1: Number of CNV association from year 1995 to 2009
studies identified by searching non-review articles in Pubmed.
The search criteria are the presence of copy number variation
and association or disease in title or abstract of the articles.
1.1 COPY NUMBER VARIATION 7
1.1.3.1 Beneficial or Adapted CNVs
CNV on the CCL3L1 gene is one example of beneficial CNVs (Burns et al., 2005;
Gonzalez et al., 2005; Kuhn et al., 2007). This gene encodes a chemokine in-
volved in immunoregulatory and inflammatory processes, and its copy number
varies from 0 to 10 (Zhang et al., 2009). The high copy number of CCL3L1 gene
was found to be associated with the increased resistance to several diseases,
including Kawasaki disease (KD) (Burns et al., 2005) and Acquired Immunode-
ficiency Syndrome (AIDS) (Gonzalez et al., 2005; Kuhn et al., 2007).
The CNV affecting salivary amylase gene (AMY1) is an example of adapted
CNV (Perry et al., 2007; Hastings et al., 2009). AMY1 gene encodes the enzyme
that is responsible for starch hydrolysis. Significantly higher copy number
of AMY1 gene was found in populations with high-starch diets than those
with traditional low-starch diets (Perry et al., 2007). The high copy number
of AMY1 gene also positively correlates with high salivary amylase protein
expression level, thus probably helps starch digestion. This suggests that high
copy number of AMY1 gene is advantageous and therefore undergoing positive
selection in high-starch diet populations (Perry et al., 2007).
1.1.3.2 CNVs Associated with Diseases
Besides the diseases described in Section 1.1.2 on page 3, CNVs are reported
to be associated with many other well-known diseases, including Parkinson’s
disease (PD), Alzheimer’s disease (AD), autism, and schizophrenia (Wain et al.,
2009; Zhang et al., 2009; Dear, 2009). Several examples of CNV-associated
diseases are listed in Table 1.1.
1.1 COPY NUMBER VARIATION 8
Triplication of α-synuclein gene was found to cause Parkinson’s disease in a
large and well characterized family (Singleton et al., 2003). The gene triplication
doubles α-synuclein protein level in blood and brain and causes formation
of Lewy bodies by the aggregated form of α-synuclein in brain, which is the
pathological hallmark of Parkinson’s disease (Miller et al., 2004; Singleton et al.,
2004; Chartier-Harlin et al., 2004). Subsequent studies observed the same
triplication in patients with Parkinson’s disease from different populations,
suggesting the direct relationship between dosage of α-synuclein gene and
Parkinson’s disease (Chiba-Falek et al., 2006; Nishioka et al., 2006; Kay et al.,
2008; Ross et al., 2008; Sironi et al., 2009).
The association of Alzheimer’s disease with CNV was discovered in 2006.
Duplication of amyloid precursor protein gene (APP) was found in five families
with the autosomal dominant early-onset Alzheimer disease (ADEOAD), but
absent in 100 controls (Rovelet-Lecrux et al., 2006). Abundant parenchymal
and vascular deposits of amyloid-beta peptides were also observed in individ-
uals with APP duplication. Later, the same APP duplication was also observed
independently in one out of ten multi-generation families with early onset
Alzheimer’s disease (Sleegers et al., 2006).
The CNVs described above for Parkinson’s disease and Alzheimer’s disease
are mostly inherited. In comparison, most of the CNVs associated with autism
and schizophrenia have arisen de novo — CNVs not detectable in parental
genomes.
de novo CNVs were observed in 12 out of 118 (10%) of patients with spo-
radic autism, but only in 2 out of 196 (1%) of controls, suggesting the sig-
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nificance of de novo CNVs as a risk factor in autism (Sebat et al., 2007). In
another study, 66 de novo CNVs were tested for association in a sample of
1,433 schizophrenia cases and 33,250 controls, and three of the de novo CNVs
significantly associate with schizophrenia (Stefansson et al., 2008). Two of the
three CNVs were also identified by International Schizophrenia Consortium
(2008), based on the study of 3,391 schizophrenia cases and 3,181 ancestrally
matched controls. In addition, it was also found that the schizophrenia cases
have significantly higher de novo CNV frequencies than the controls (Interna-
tional Schizophrenia Consortium, 2008).




Alzheimer disease 21 0.5 Mb Rovelet-Lecrux et al.
(2006); Sleegers et al.
(2006); Cabrejo et al.




many many Sebat et al. (2007); Berg
et al. (2007); Weiss et al.
(2008); Kumar et al.
(2008); Morrow et al.
(2008); Fernandez et al.
(2009); Pagnamenta
et al. (2009)
Cat-eye syndrome 22 17 Mb Footz et al. (2001);
McDermid and Morrow




17 0.5 Mb Lupski et al. (1991,
1992)
Continued on next page . . .
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Cri-du-chat syndrome 5 11.7 Mb Medina et al. (2000);
Mainardi et al. (2001)
Di George syndrome 22 3.7 Mb Guris et al. (2006);
Ryan et al. (1997)
Down syndrome 21 47 Mb Lejeune et al. (1959);
Korbel et al. (2009)
Familial adenomatous
polyposis
5 0.1 Mb Sieber et al. (2002);
Michils et al. (2005)
Hereditary liability to
pressure palsies
17 1.5 Mb Chance et al. (1993)
Leri-Weill
dyschondrostosis
X 0.1 Mb Schneider et al. (2005);
Zinn et al. (2006);
Benito-Sanz et al.
(2006)
Miller-Dieker syndrome 17 2.5 Mb Yingling et al. (2003);
Cardoso et al. (2003)
Parkinson disease 4 0.1 Mb Singleton et al. (2003);
Miller et al. (2004);
Chartier-Harlin et al.
(2004); Chiba-Falek
et al. (2006); Kay et al.
(2008); Ross et al.




X 0.5 Mb Inoue et al. (2002); Gao
et al. (2005)
Potocki-Lupski syndrome 17 3.8 Mb Potocki et al. (2000);
Shaw et al. (2002, 2004)
Potocki-Shaffer syndrome 11 2 Mb Wakui et al. (2005)
Continued on next page . . .
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et al. (2008); Walsh
et al. (2008); Sebat et al.
(2009); Ikeda et al.
(2009); Kirov et al.
(2009); McCarthy et al.
(2009); Kirov (2010)
Smith-Magenis syndrome 17 3.7 Mb Chen et al. (1997);
Shaw et al. (2002, 2004)
Williams-Beuren
syndrome
7 2.3 Mb Osborne et al. (2001);
Bayés et al. (2003)
1.2 CNV Detection Methods
1.2.1 Fluorescent in situ Hybridization
Fluorescent in situ Hybridization (FISH) can be used to detect DNA copy
number changes (Figure 1.2). In a FISH experiment, interphase or metaphase
chromosomes from both the test and reference samples are fixed on a glass
slide. To test the copy number of a particular chromosome region, fluorescent
probes are generated using polymerase chain reaction (PCR). The fluorescent
labeled probes are then hybridized to the fixed chromosomes from test and
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reference individuals. The copy number of the interested regions are then
counted using fluorescence microscopy and compared between the test and
reference samples (Guerra, 2001; Landstrom and Tefferi, 2006; Lambros et al.,
2007).
The FISH method is a very important tool in tumor biology, because it can
be used to study both copy number changes and balanced rearrangements of
DNA segments. However, the FISH method has two major drawbacks. Firstly,
the resolution of FISH is low (5 – 10 Mb) (Carter, 2007). Secondly, due to the
requirement of handling individual chromosomes, the FISH method cannot
be scaled up for genome-wide CNV detection.
1.2.2 Quantitative Real-Time PCR
Another method used for CNV detection is quantitative Real-Time PCR (RT-
PCR) (Braude et al., 2006; Lee and Jeon, 2008). In RT-PCR approach, the quan-
tity of a DNA segment is directly measured using locus-specific PCR primers.
The copy numbers of interesting segments are then estimated based on the
measured quantities from a test and a reference sample. The major disadvan-
tage of RT-PCR is that it is locus-specific and therefore cannot be applied to
genome-wide detection, similar to FISH. However, the measured quantity in
RT-PCR is more accurate than hybridization-based methods, such as FISH (Yu
et al., 2009).




















Figure 1.2: Fluorescent in situ Hybridization (FISH). In FISH
experiment, interphase or metaphase chromosomes from test
and reference samples are fixed on glass slides. The genomic
region of interest is then amplified by PCR. The PCR products
are fluorescent labelled and hybridized to the chromosomes
on glass. The copy number of the interested region in both
samples are counted using microscopy.
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1.2.3 Array Comparative Genomic Hybridization
The most common way to detect CNV is to utilize microarray-based meth-
ods (Albertson and Pinkel, 2003; Pinkel and Albertson, 2005b,a; Carter, 2007).
Array-based Comparative Genomic Hybridization (aCGH) was first used to
detect CNV a decade ago (Solinas-Toldo et al., 1997; Pinkel et al., 1998). In
aCGH, a microarray containing probes that cover the whole genome is used
for hybridization with sample test and reference genomic DNA (Figure 1.3).
The hybridization probes on the microarray can be bacterial artificial chromo-
somes (BACs) (Snijders et al., 2004), cDNAs (Pollack et al., 1999), or oligonu-
cleotides (Carvalho et al., 2004; Brennan et al., 2004). The genomic test and
reference DNA are fragmented, differentially labeled, and then co-hybridized
to the microarray. The relative abundance of test and reference DNA at each
microarray-probe position are measured by the ratio of fluorescent intensity
signals, representing the DNA copy number ratios between the test and ref-
erence genomes. The major advantage of aCGH over FISH and RT-PCR is
that, because probes representing the whole genome are in one microarray,
genome-wide CNVs are simultaneously studied in aCGH (Figure 1.3).
The principle of aCGH is similar to FISH approach, but with two key dif-
ferences. In the FISH method, the interphase or metaphase chromosomes
are used for hybridization, whereas in aCGH a microarray representing all
genomic DNAs are used. Another difference is that in FISH, the intact test and
reference chromosomes are used as a template for hybridization, whereas in
aCGH it is directly opposite — the test and reference samples are fragmented
and hybridized to a microarray of probes.
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Figure 1.3: Schematic view of array-based Comparative Ge-
nomic Hybridization. Genomic fragments from test and refer-
ence samples are differentially labeled and co-hybridized to a
microarray with probes covering the whole genome. Relative
fluorescent intensities of hybridized samples at each probe are
compared, and thus DNA copy number ratios in the original
samples can be inferred.
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There are several inherent limitations in microarray-based approaches
(Shendure, 2008). The resolution of CNV detection is limited by the probe size
and density on the array and thus cannot be able to be flexibly adjusted. The
assumption that fluorescent intensity is linearly correlated with quantity of
hybridized DNA fragments has shown to not be true (Stekel, 2003). Therefore,
it is difficult to use microarray approach for accurate quantification of low-
or high-abundance DNA fragments, resulting from limited dynamic range.
A further complication is that, cross-hybridization often ambiguities in the
interpretation of signals from short oligo microarrays (Okoniewski and Miller,
2006; Royce et al., 2007). In addition, microarray-based methods usually have
reproducibility problems (Levy et al., 2007; Shendure, 2008).
1.2.4 SNP Genotyping Arrays
SNP genotyping arrays are widely used in high-throughput identification of
SNPs. On a SNP genotyping array, each SNP allele is represented by matched
and mismatched groups of probes approximately 25 bp long. Due to the high
density of SNPs in human genome, the density of oligonucleotide probes on
genotyping arrays is very high, which enables the arrays to be used for CNV
detection (Carter, 2007). Unlike in aCGH, where test and reference samples
are co-hybridized to an array, only test sample DNA is hybridized to a SNP
genotyping array. In order to identify CNVs between two individuals, the DNA
fragments of the two individuals are hybridized to two separate arrays. The
computation of the fluorescence intensities of probe groups on two arrays
yields an estimate of DNA copy number ratio (Figure 1.4).
1.2 CNV DETECTION METHODS 17





























Figure 1.4: Schematic view of CNV detection using SNP geno-
typing arrays. Unlike in aCGH, test and reference samples are
not co-hybridized to the same microarray.
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Besides the general limitations of all microarray-based methods described
in Section 1.2.3, there are several additional drawbacks specific to SNP geno-
typing arrays. Firstly, when using SNP genotyping array to detect CNV, am-
plification of restriction enzyme digested DNA is usually required to improve
signal-noise ratio. The extra digestion and amplification steps introduce po-
tential sampling bias and possible false CNV calling (Carter, 2007). Secondly,
although SNP probes are of high density, the probes on the array are not
uniformly distributed through a genome, which results in uneven detection
resolution across the genome. Thirdly, the separate hybridization process, in-
stead of co-hybridization, introduces yet another level of bias, which can lead
to false positive CNV calls.
1.2.5 Analytical Methods for aCGH Data
In the last decade, array-based Comparative Genomic Hybridization (aCGH)
has been widely used in CNV detection. Not surprisingly, many methods for
analyzing aCGH data were developed (Pollack et al., 1999; Albertson and Pinkel,
2003; Lai et al., 2005; Shah et al., 2006; Komura et al., 2006). There are two
major tasks for the CNV detection data analysis. The first task is to locate a
CNV and report its boundary in the genome. The second is to estimate the
DNA copy number ratios in the detected CNV region. A simple approach to
solve the two tasks would be to set a copy number ratio threshold and to look
for genomic regions with fluorescent ratios exceeding the pre-set threshold.
However, the problem with this approach is high-level of false positive calls,
which is the reason that various more advanced analytical methods have been
developed.
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The advanced analytical methods for aCGH broadly fall into three classes.
The first class is smoothing methods, where copy number ratios for probes
with adjacent locations are smoothed through either weighted or un-weighted
average. The smoothing procedure could remove many single-probe noises,
and only regions covering multiple probes with copy number ratios exceed-
ing a threshold are classified as CNV regions (Eilers and de Menezes, 2005).
The second class is segmentation or change-point analysis. An example was
Circular Binary Segmentation (CBS) method, which is a novel modification
of binary segmentation to recursively divide genomic regions into segments
with equal copy number ratios (Olshen and Venkatraman, 2002; Olshen et al.,
2004; Venkatraman and Olshen, 2007). The last class of analytical methods is
Hidden Markov Model (HMM) approaches, which simultaneously solve the
two tasks with a sophisticated statistical framework. Fridlyand et al. (2004) first
applied HMM approach to aCGH data, where the spatial coherence between
nearby clones are utilized to partition the clones into states which represent
the underlying copy number ratios.
1.3 Development of DNA Sequencing Technologies
The rapid development of sequencing technologies is continuously increasing
the speed and decreasing the cost of DNA sequencing. The next-generation
sequencing, such as 454 (Margulies et al., 2005), Illumina (Bentley, 2006) and
SOLiD (Valouev et al., 2008) have already shown advantages over microar-
rays in several aspects. Apart from being rapid and cheap, data produced
by sequencing can be re-used for varied purposes as opposed to data from
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microarray-based methods that usually can only be used for one specific study.
In addition, reproducibility has been one of the major challenges for microar-
ray technology, but not in sequencing based platforms (Shendure, 2008). The
once revolutionizing microarray-based ChIP-Chip technology is being replaced
by ChIP-seq, in which the DNA fragments are sequenced instead of being hy-
bridized to an array (Johnson et al., 2007). Sequencing-based methods are also
used to produce genome-wide DNA methylation profiles, detect SNP, and RNA
transcriptome profiling (Chen et al., 2008; Cokus et al., 2008; Hillier et al., 2008;
Marioni et al., 2008; Mortazavi et al., 2008; Nagalakshmi et al., 2008; Wilhelm
et al., 2008; Van Tassell et al., 2008). The development of DNA sequencing
technologies is briefly reviewed in this section.
1.3.1 The Sanger Sequencing Technology
One of the first DNA sequencing methods was developed by Maxam, A. M. and
Gilbert, W. in 1977(Maxam and Gilbert, 1977). The method is based chemical
modification of DNA and cleavage at specific bases. However, due to difficul-
ties in scaling up and heavy use of harmful chemicals in the Maxam-Gilbert
method, the Sanger sequencing method developed in 1975–1977 by Sanger
et al. is much more popular (Sanger and Coulson, 1975; Sanger et al., 1977).
The principle of Sanger sequencing is based on that, the position of a certain
nucleotide (A, T, G, or C) in a DNA fragment can be determined by amplify-
ing DNA fragments and terminating the amplification reactions at specific
nucleotides. The key component of the method are 2’,3’-dideoxynucleotides
(ddNTPs), which are similar to normal dexoynucleotide (dNTP) but will ter-
minate further amplification reaction when incorporated. A DNA fragment
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Figure 1.5: Principles of the Sanger sequencing technology. La-
beled ddNTPs will terminate DNA polymerase reaction. Mea-
suring the length of the terminated growing chain can identify
the nucleotide at the position where chain termination oc-
curred.
is first denatured to single strands, as templates for amplification reaction.
Four separate amplification reactions are carried out in order to determine
the positions of all four types of nucleotides in the DNA fragment. The ddNTP-
terminated amplification products are then separated using polyacrylamide gel
electrophoresis, and the order of the nucleotide sequence can be determined
by measuring the length of the amplification products (Figure 1.5).
Various efforts have been devoted to improve the speed and cost of Sanger
sequencing technology, such as refined fluorescence detection methods (Smith
et al., 1986; Prober et al., 1987) and new fluorescent dyes (Ju et al., 1995; Met-
zker et al., 1996), but the most effective improvement was the use of capillary
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electrophoresis (Takahashi et al., 1994; Kheterpal et al., 1996). The current high-
throughput automated capillary DNA sequencer (ABI3730xl Genome Analyzer)
can sequence 30 to 70 Kb per hour at cost of about one dollar per Kb , and the
read length is about 700 to 900 bases in routine production (Morozova et al.,
2009). The advancements in Sanger sequencing have helped the completion
of the Human Genome Project (Collins et al., 2003), however, routine human
genome sequencing is still not feasible — the cost of the personal genome of
Craig Venter was about 70 million dollars using the Sanger technology (Levy
et al., 2007).
1.3.2 The Next-Generation Sequencing
Although capillary array electrophoresis improved the traditional Sanger se-
quencing technology, the electrophoresis step is still the bottleneck of high-
throughput automated sequencing (Metzker, 2005). In recent years, several
novel sequencing technologies emerged, collectively named the next-generation
sequencing technologies (or second generation sequencing). Though each
technology is based on a separate principle, they all share one common char-
acteristics — electrophoresis is not needed, allowing the next-generation meth-
ods to be much faster and cheaper than the Sanger sequencing (Marziali and
Akeson, 2001; Metzker, 2005; Mardis, 2008b; Ansorge, 2009; Simon et al., 2009;
Voelkerding et al., 2009; Metzker, 2010). The three most widely used next-
generation technologies are described below.
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1.3.2.1 Roche’s 454 Pyrosequencer
Pyrosequencing was first described in 1985 (Nyrén and Lundin, 1985; Hyman,
1988). The first next-generation automated sequencer was the 454 Pyrose-
quencer, introduced in 2005 (Margulies et al., 2005). The Pyrosequencer per-
forms massively parallel pyrosequencing reactions to improve sequencing
throughput. The basis of pyrosequencing is illustrated in Figure 1.6. When
amplifying a single stranded DNA fragment, each nucleotide incorporation
by DNA polymerase will generate a pyrophosphate. ATP sulfurylase will then
convert the pyrophosphate to ATP, which will then emit light by luciferase. By
adding only one type of nucleotide and measuring the intensity of the emitted
light, the number of specific nucleotides incorporated can be calculated. The
four types of nucleotides are added repeatedly, and the whole sequence of the
DNA can be determined (Figure 1.6).
The 454 Pyrosequencer uses nano technology to carry out large amount of
pyrosequencing reaction in parallel (Figure 1.7) (Margulies et al., 2005; Droege
and Hill, 2008). DNA fragments are first ligated with adaptors, and then dena-
tured to single strands. The single strand DNA is captured by micro-beads via
the adaptors. Each bead will only capture one DNA fragment. Then the DNA
on each bead is amplified by PCR, in water droplets with PCR reagents im-
mersed in oil, to increase signal intensity for later stage. The beads are loaded
to wells of 44 µm diameter on an optical fibre chip, and each well can only
hold one bead. Pyrosequencing reactions are then carried out in the wells in
parallel, and sensitive CCD camera will capture the DNA sequences in all the
wells.











Figure 1.6: Principles of pyrosequencing. Pyrophosphate will
be generated during DNA polymerase reaction. A series of
subsequent reactions can lead to light emission, which can
be used to calculate the number of nucleotide incorporated.
By controlling the type of nucleotide added each time, the
template DNA sequence can be determined.











Figure 1.7: Schematic view of sequencing procedure by 454
pyrosequencer. Single strand DNA fragments are attached to
micro-beads and amplified by emulsion PCR. Pyrosequenc-
ing reactions on each bead are carried out in micro-wells in
parallel.
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Currently the 454 Pyrosequencer can produce in average 300 bases long
reads, at a rate of 13 Mb per hour, which is much higher than the Sanger tech-
nology (30 to 70 Kb per hour) (Morozova et al., 2009). The first few applications
of the 454 Pyrosequencer were microbial genome sequencing (Edwards et al.,
2006; Goldberg et al., 2006), but that soon expanded to human genome. The
second human personal genome, James Watson’s genome, was sequenced
in 2008 using 454 technology (Wheeler et al., 2008). Compared with Venter’s
genome, which cost 70 million dollars, Watson’s genome cost only one million
dollars by utilizing a re-sequencing procedure (Levy et al., 2007; Wheeler et al.,
2008).
1.3.2.2 Illumina Genome Analyzer
The second next-generation sequencer available is the Illumina Genome Ana-
lyzer, which was introduced in 2006 (Ansorge, 2009). The Illumina sequencing
is based on sequencing-by-synthesis chemistry, as shown in Figure 1.8. In
this approach, special dNTP analogues are used in template-dependent DNA
synthesis by DNA polymerase. The four dNTP analogues are differentially fluo-
rescent labeled and 3’ blocked, so that only one nucleotide can be incorporated
by DNA polymerase and the identity of the nucleotide can be detected based
on the fluorescent dye on the nucleotide. The fluorescent dye and 3’ blocking
cap are then removed, so that the next nucleotide can be added and detected.
The process is repeated and the sequence of the original DNA template can be
determined (Figure 1.8).
The Illumina Genome Analyzer can achieve high-throughput due to the
large number of mini sequencing-by-synthesis reactions carried out parallelly





















Figure 1.8: Schematic illustration of sequencing-by-synthesis
reactions. Differentially labeled nucleotides are incorporated
into the growing chain of DNA polymerase reaction. By mea-
suring the fluorescent signals, the sequence of the template
DNA can be determined.
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on a micro-chip (Bentley, 2006), as shown in Figure 1.9. Single strand DNA frag-
ments linked with specific adaptors are prepared similarly to 454 sequencing,
but Illumina uses bridge PCR to amplify the single strand DNA library. These
single strand DNA fragments are bound to flow cell surface, via the hybridiza-
tion between the adaptor in each DNA fragment and primers on the flow cell
surface. Each bound DNA fragment will form a bridge PCR reaction with a free
primer on the flow cell. The bridge PCR will amplify each bound DNA frag-
ment to a cluster. All clusters of amplification products on the flow cell surface
will then be used as template for massively parallel sequencing-by-synthesis
reactions (Figure 1.9).
The current Illumina Genome Analyzer can sequence 25 Mb per hour,
which is twice as fast as the 454 Pyrosequencer, however, the reads produced
by Illumina sequencer is less than 40 bases long in the initial generation (Mo-
rozova et al., 2009). Although the current technology can produce read length
of 75 bases, the reads are still to short short to make de novo assembling of
large genomes. One strategy to produce complete genome sequence is by
mapping the short reads to a reference assembly and then use the consensus
sequence (Wang et al., 2008; Bentley et al., 2008; Ahn et al., 2009). The massive
high-throughput of the Illumina sequencing technology largely out-weights
the limitation of short read-length in many applications where read-length is
not as important as the number of reads (see Section 1.3.4).
1.3.2.3 SOLiD Sequencer from Applied Biosystems
The SOLiD sequencer was introduced in 2007 by Applied Biosystems (Valouev
et al., 2008; Schuster, 2008). The SOLiD system utilizes sequencing-by-ligation
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Figure 1.9: Schematic view of sequencing procedure by Il-
lumina Genome Analyzer. Single strand DNA fragments are
attached to flow cell surface, where the fragments are ampli-
fied by bridge PCR. The clusters of amplified DNA fragments
are sequenced using sequencing-by-synthesis reactions in par-
allel.
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technology (Figure 1.10). In sequencing-by-ligation reaction, a primer is first
bound to an adaptor DNA linked to the template DNA fragment to be se-
quenced. Four species of fluorescent oligonucleotide probes are added and
a ligase will ligate the primer with the probes whose first and second bases
complement the template sequence. Each of the four species contains differ-
ent nucleotides at the first two positions, that are labeled with different dyes.
By measuring the fluorescence after washing out un-ligated probes, two nu-
cleotide sequences can be determined. The process is repeated with different
sets of probes, and the sequence of the template DNA can be determined
(Figure 1.10).
The overall design of SOLiD sequencer is similar to the 454 sequencer (Fig-
ures 1.7 and 1.11). In both systems, single strand DNA fragments linked to
adaptors are prepared, and bound to beads where emulsion PCR is carried
out in order to amplify DNA fragments. Instead of loading the beads to wells
on a chip as in the 454 sequencer, the SOLiD system modifies 3’ end of all
bead-bound DNA fragments. The 3’ end modification will allow covalent bond-
ing to a glass slide, where parallel sequencing-by-ligation will be carried out.
This well-free approach means that, the density of beads on each slide are
not constrained by the number of wells each slide can hold, thus potential
improvement of throughput is much easier in the SOLiD system than in the
454 technology.
The SOLiD Sequencer can produce 21 to 28 Mb of sequence per hour in
2008, and the sequencing read length is about 35 bases (Ansorge, 2009). In
2009, Applied Biosystems released a new version of sequencer — SOLiD 3,
which can sequence the entire human genome at 17-fold coverage in a single






















Figure 1.10: Schematic illustration of sequencing by liga-
tion reaction. Instead of incorporating single nucleotides as
in sequencing-by-synthesis reactions, differentially labeled
oligonucleotides are ligated to the growing chain. By mea-
suring the different fluorescent signals, the sequence of the
template DNA can be determined.












Figure 1.11: Schematic view of sequencing procedure by ABI
SOLiD Sequencer. Single strand DNA fragments are attached
to micro-beads and amplified by emulsion PCR. The micro-
beads are then bound to glass slide via the 3’ end modification
of the DNA on the beads. Parallel sequencing-by-ligation reac-
tions are carried out on the glass slide.
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run (McKernan et al., 2009).
1.3.3 The Third-Generation Sequencing
The next-generation sequencing technologies described in the previous section
are collectively called the second generation technologies. While the second-
generation sequencing technologies are revolutionizing our biological research,
the third-generation technologies are around the corner (Check Hayden, 2009).
One common problem for all next-generation technologies is that PCR amplifi-
cation, either emulsion PCR or bridge PCR, is required to improve sequencing
signals. The third-generation technologies do not need the PCR amplifica-
tion; instead, they are all single-molecule sequencing (Braslavsky et al., 2003;
Greenleaf and Block, 2006; Harris et al., 2008; Eid et al., 2009). Single-molecule
sequencing not only decreases cost but also improves throughput, because
in the next-generation system reactions on multiple copies of the same DNA
fragment can only produce one sequencing read, but in the third-generation
sequencing, any single DNA molecule can produce a sequencing read. Accu-
racy of sequencing is also expected to be improved due to the elimination of
the amplification step, which is error prone.
The first single-molecule sequencer released is the Heliscope Single Molecule
Sequencer, which can in real time and in parallel follow one billion molecules
while they are being sequenced (Pushkarev et al., 2009). A personal genome was
sequenced using the Heliscope Sequencer in 2009 at cost bellow 0.5 million
dollars (Pushkarev et al., 2009). The Heliscope system uses sequencing-by-
synthesis method (Figure 1.8 on page 27). Unlike the Illumina system, which
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adds four differentially labeled nucleotides at the same time, the Heliscope
system add only one of the four nucleotides each cycle, which can further
reduce cost.
Another third-generation system, developed by Pacific Biosciences, also
uses sequencing-by-synthesis, but the nucleotide analogues they use will not
block the DNA synthesis reaction, instead, the analogues will only pause the
DNA polymerase for a short time enough for the sequencer to identify the
incorporated nucleotides (Eid et al., 2009). The pause-not-block approach can
further improve sequencing speed and cost due to the elimination of the cap
removal and wash step. The Pacific Biosciences is expected to sequence 100
Gb per hour, which is equivalent to one-fold human genome coverage in 4
minutes (Ansorge, 2009).
Quantum Dot sequencing, or QDot, is another third-generation technology
for single molecule sequencing. The polymerase used in QDot is attached with
a quantum dot, which emits light. The light emitted from the quantum dot will
excite the base-specific dye on the nucleotide that is being incorporated to the
growing DNA chain by the polymerase, due to close proximity and fluorescence
resonance energy transfer.
The key feature of QDot is that it allows unlimited length of sequencing.
The short read length of current technologies is mostly due to polymerase
degradation and error propagation during long run of a single reaction. In the
QDot technology, sequencing reactions can be interrupted, and reagents and
polymerases are then washed. After adding new polymerase and reagents, the
interrupted sequencing reactions can be restarted, thus continuing previous
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reading. It is very interesting that this could be used on in situ sequencing,
eliminating the necessaries of assembling shotgun sequencing fragments in
order to sequence a chromosome.
Nanopore based technology is yet another promising third-generation tech-
nology (Deamer and Akeson, 2000; Fologea et al., 2005; Ashkenasy et al., 2005;
Astier et al., 2006; Trepagnier et al., 2007). The principle of nanopore approach
is based on artificial nanopores with diameter of one nanometer (Kasianowicz
et al., 1996). A nanopore is an artificial pore with diameter of one nanometer.
When a nanopore is placed in conducting fluid with voltage across, an electric
current through the pore can be observed. The current is easily modulated by
the size and ionic state of the nanopore. If a single strand DNA is translocat-
ing through the nanopore, both the size and ionic state within the nanopore
changes, and thus the electric current changes too. Different nucleotides pass-
ing through the pore will have different effects on current change. By observing
the changes in electric current while a DNA molecule is driven through the
nanopore, the nucleotide sequence of the DNA molecule passing through can
be determined. The advantage of nanopore sequencing is that there are no
biological reactions, chemical modifications or optical detection required, thus
reducing cost and increasing throughput compared to sequencing-by-synthesis
approaches (Figure 1.12).
1.3.4 Applications of Next-Generation Sequencing
The new sequencing technologies are transforming the way we perform ge-
nomic research (Schuster, 2008). More and more traditional microarray-based
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Figure 1.12: Principle of nanopore sequencing technologies.
A. Nanopores are artificial pores with diameter of 1 nanometer.
B. When a voltage is applied to across the pore, electric cur-
rent can be observed. C. When a single strand DNA molecule
is passing through the pore, the electric current changes. By
measuring the changes of electric current, the sequence of the
DNA can be determined.
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applications are replaced by sequencing-based approaches; partially because
the large number of sequencing reads exceed the content and dynamic range
of microarrays without the confinement of available arrays (Shendure, 2008;
McPherson, 2009). Three examples of the transition are described here.
1.3.4.1 ChIP-seq
The first microarray application replaced by sequencing was ChIP-chip. ChIP-
chip couples the traditional Chromatin Immunoprecipitation (ChIP)(Solomon
et al., 1988) with microarray chips to identify genome-wide protein-DNA inter-
actions, that is essential to the understanding of gene regulation and chromatin
dynamics (Blat and Kleckner, 1999; Ren et al., 2000). In a ChIP-chip experi-
ment, DNA-binding proteins are first cross-linked with chromatin DNA that
they bind to. Then the DNA is fragmented and enriched using an antibody
that is specific to the protein of interest. The DNA fragments are separated
from the protein, and the identity and quantity of the enriched DNA are then
determined using a microarray chip (Blat and Kleckner, 1999; Ren et al., 2000;
Park, 2009).
Along with the development of new generation technologies, an increasing
number of experiments utilize sequencing approach, ChIP-seq, coupled ChIP
with sequencing instead of microarray (Johnson et al., 2007; Mikkelsen et al.,
2007; Robertson et al., 2007; Barski et al., 2007; Robertson et al., 2008; Park,
2009). Besides cost and high throughput potential, ChIP-seq has several other
advantages over ChIP-chip. Single-nucleotide resolution is possible in ChIP-
seq, while the resolution in ChIP-chip is array specific, approximately 30 to
100 bases. The amount of DNA required for a ChIP-seq experiment is about
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100 times lower than that of ChIP-chip (Barski and Zhao, 2009; Pepke et al.,
2009). Other common limitations of microarrays, such as cross-hybridization
and limited dynamic range, are also overcomed in sequencing-based ChIP-seq
(Park, 2009).
1.3.4.2 RNA-seq
Analysis of genome-wide gene expression was one of the major applications
for microarrays, but now a sequencing-based method, RNA-seq, is becoming
widely used instead (Morozova et al., 2009; Simon et al., 2009; Wang et al.,
2009). In a microarray-based method, transcribed RNA molecules, or their
cDNAs, are hybridized to a DNA microarray, and the abundance of RNAs are
interpreted from the fluorescence signals at each probe. In contrast, the cDNA
of transcribed RNAs are sequenced in RNA-seq. Therefore instead of interpret-
ing abundance based on hybridization, the exact identity and quantity of RNA
molecules are directly obtained in RNA-seq. Besides solving the inherited limi-
tations of microarray-based methods, as discussed in Section 1.2.3, the major
advantage of RNA-seq is that, in a single RNA-seq experiment, the complete
transcriptome profile can be determined, which includes alternative splicing,
RNA editing, and fusion transcripts (McPherson, 2009; Medvedev et al., 2009).
1.3.4.3 BS-seq
Genome-wide DNA methylation was traditionally studied using microarray-
based method, either MeDIP-chip (Methyl-DNA immunoprecipitation on chip)
or McrBC-chip (Methylation dependent restiction endonuclease B anc C operon).
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In MeDIP-chip, methylated DNA are enriched using antibody specific to methy-
lated cytosine, and then using a microarray, the abundance of enriched DNA
are compared with a reference sample where methylated DNA are not enriched
(Cheng et al., 2008; Weng et al., 2009). The McrBC-chip method is similar, but
the methylated DNA is not enriched, instead, they are digested and depleted
by the enzyme McrBC (Ibrahim et al., 2006). The key problem of the two
microarray-based methods is low resolution, due to the detection being linked
to the identity of DNA fragments where methylation occurred and not the
identity of individual nucleotides.
Sequencing-based methods solve this resolution problem. Bisulphite se-
quencing was first used to study DNA methylation at single nucleotide resolu-
tion in 1994 (Grigg and Clark, 1994; Grigg, 1996). The principle of bisulphite
sequencing is that, normal cytosine can be converted to uracil by bisulphite
treatment, but methylated cytosine cannot. Therefore, by identifying remaining
cytosines via sequencing after bisulphite treatment, exact position of methy-
lation can be determined. BS-seq combines bisulphite sequencing with the
high-throughput sequencing technologies, and allows studies of genome-wide
DNA methylation at single nucleotide resolution (Cokus et al., 2008; Lister and
Ecker, 2009).
1.4 Simple Method to Detect CNV by Sequencing
Variation in sequencing coverage of a shotgun sequencing data set over a ref-
erence genome assembly has been used as an indicator for potential CNVs
(Sherwood, 2007; Wheeler et al., 2008). This approach is analogous to a com-
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parison of copy number between a single set of DNA fragments and microarray
probes. There are three major problems with this kind of approach. Given a
certain hybridization condition, hybridization efficiency varies among microar-
ray probes. Likewise, given a certain alignment threshold, sequencing errors
in combination with differences between genomes may result in erroneous
distribution of the reads (Degner et al., 2009). Secondly, the number of probes
on a microarray does not represent the real copy number of probe sequences
in a genome. Likewise, the copy number of DNA segments in an assembled
reference genome may not represent the true one. Notably, the regions con-
taining multiple copies are the most difficult part to assemble correctly and
are still the key unsolved problems in shotgun assembly (Tammi et al., 2003).
Assembly errors like these will cause variation in the sequencing coverage and
thus yield erroneous indications of CNVs. Another problem of this approach is
that the normal variation of sequencing coverage arising from simple shotgun
sampling process is not considered, and this also leads to apparent variation
of sequencing read depth.
As a result of these problems, observed sequencing coverage changes are of-
ten not a result of real DNA copy number changes. For example, in Figure 1.13,
the number of reads per window (5 Kb) between Watson’s genome (Wheeler
et al., 2008) and Venter’s genome (Levy et al., 2007) are strongly correlated
(Spearman’s rank correlation, ρ = 0.942, p-value < 2.2×10−16), and not likely
due to DNA copy number changes. Therefore, more sophisticated methods
need to be developed to solve all these problems.
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Figure 1.13: Problems of simple read depth analysis. Sequenc-
ing coverage changes can be caused by many factors other
than DNA copy number changes in the genome, therefore, sim-
ple read depth analysis will often lead to false CNV calls. The
read depth data for a region in Watson’s and Venter’s genomes
are shown here.
1.5 Contributions of This Study
Here we describe a robust statistical model which gives the framework for the
analysis of CNV by sequencing. The implemented method, CNV-seq combines
the advantages of aCGH and high throughput sequencing (Xie and Tammi,
2009). We were the first to describe a full framework for a sequencing-based
CNV analysis.
Based on our CNV-seq framework, we also developed a two-stage Hidden
Markov Model approach capable of achieving a resolution that is the average
distance between two adjacent sequencing reads. This method is the first to
utilize information from each single, instead of a group of, DNA reads, and
thus achieves highest resolution possible for a given data set.
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Our methods are tested with simulated data, and are applied on real se-
quencing data for CNV identification. Implementations of our methods are
freely available at http://tiger.dbs.nus.edu.sg/CNV-seq and http://code.
google.com/p/seghmm. Given the rise of the new generation of sequencing
technologies, we expect our method will be more and more widely used.
2
The Statistical Model for CNV-seq
2.1 Introduction
A straightforward attempt to detect CNV using sequencing would be simply
counting the sequencing coverage along a reference genome assembly. DNA
segments with higher than average coverage would be classified as copy num-
ber gained region, while segments with lower than average coverage would be
copy number lost region.
However, there are three major problems in this approach. First, this method
is comparing copy numbers of DNA between one individual genome and a
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reference genome assembly. The key assumption in this comparison is that,
the copy number of each DNA segment in the reference assembly represents
its real copy number in a genome. This assumption is however not true —
copy number variable regions in a genome are exactly the regions that are
hard to assemble correctly when constructing reference assembly. It is usually
not clear whether two similar sequencing reads are from two related genomic
regions or from a single region with sequencing errors (Tammi et al., 2003).
Therefore, the true copy numbers of CNV-susceptible regions are usually not
accurate in reference genome assemblies.
Another problem with the simple read-depth analysis is that, differential
complexities across a genome can affect observed sequencing coverage or read
depth, due to bias in DNA sequencing and sequencing read mapping (Degner
et al., 2009). DNA sequencing technologies produce biased output. Certain
DNA sequences are enriched, while some sequences are depleted depending
on the composition of the DNA sequence. Mapping of sequencing reads to a
reference assembly is also affected by the complexity of the genome — similar
to the fact that DNA-probe hybridization efficiency in microarray experiments
is affected by the sequence of the probes.
In addition, normal shotgun sequencing procedure will also produce un-
even coverage along the genome due to the natural variation in random sam-
pling, which will also contribute to false CNV calls by the simple read depth
analysis.
Therefore we set on to develop CNV-seq to solve the problems, and to
enable CNV detection using the new generation sequencing technologies. The
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statistical framework for CNV-seq is described in this chapter.
2.2 The CNV-seq Model
2.2.1 Overview of CNV-seq
CNV-seq method is based on a robust statistical model that allows confidence
assessment of observed copy number ratios and is conceptually derived from
the microarray-based method, aCGH (Figure 2.1). The aCGH method uses a
whole genome microarray where two sets of labeled genomic fragments are
hybridized. The fluorescent intensities of hybridized DNA fragments at each
probe are measured and compared on the array. Instead of using a microarray,
CNV-seq uses a template genome assembly for the role of the array in aCGH,
and two sets of shotgun reads, one set from each target individual, X and
Y , for the role of labeled genomic fragments in aCGH (Figure 2.1). The two
sets of shotgun reads are mapped by sequence alignment on the template
genome assembly. We use a sliding window approach in this stage to analyze
the mapped regions and CNVs are detected by computing the number of reads
for each individual in each of the windows, yielding ratios. These observed
ratios are assessed by the computation of a probability of a random occurrence,
given no copy number variation.
By the usage of both a test and a reference samples, this approach solves
the first two problems that simple read-depth method is facing — dependence
of accurate copy number in reference genome assembly and bias of sequencing
and mapping due to varied genome complexity across a genome.
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Figure 2.1: A comparison of the conceptual steps in aCGH
and CNV-seq methods. 1). Starting material in both cases is
genomic fragments from two genomes. 2). In CNV-seq the
fragments are samples and sequenced. 3). Genomic fragments
are directly hybridized on to an array. In CNV-seq the mapping
is performed by sequence alignment. 4). In microarray the
light intensities reflect the number of hybridized fragments.
In CNV-seq the number of mapped reads are counted directly.
5). Data analysis, including estimation of copy number ratios,
confidence values, etc. 6). Output of the results.
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Firstly, CNV-seq method does not compare the copy number of a DNA
segment in one individual genome to the copy number of the segment in the
reference assembly. Instead, we compare the copy numbers of two individuals
— the test individual and a control or reference individual. The template se-
quence from the assembly is used as a reference to the identity, not the copy
number, of the genomic segments, therefore the accuracy of copy numbers in
the template assembly is not important in CNV-seq.
The second problem is solved also by taking ratios of two sets of data.
Because the same template genome assembly is used for the mapping, any
bias due to differential complexity across the genome can be canceled by
comparing the sequencing data from two individuals, as long as the two sets of
data are generated in the same way — same sequencing and mapping methods.
Assuming most part of the genomes compared are not copy number varied,
the observed read count ratio in CNV-seq can be normalized using the median
of all ratios, so that the sequencing coverage of the two genomes compared
have less effect on CNV detection.
To solve the third problem of simple read depth analysis, and to make con-
fidence assessments in CNV-seq, several key questions need to be answered.
How many sequencing reads are required for CNV-seq? What is the best win-
dow size to use? What is the effect of the length of sequencing reads? Those
questions are all interconnected, and will be covered in the remaining part of
this chapter.
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2.2.2 Statistical Model of Shotgun Sequencing
The input data for CNV-seq is two sets of shotgun sequencing data for two
genomes to be compared. However, the random sampling process in shotgun
sequencing results in uneven coverage that may lead to observed coverage
ratios that falsely imply CNV. Therefore, a statistical model is essential for the
assessment of the probability of false positive ratios. In order to calculate the
confidence value for an observed ratio, or the probability of observing equal or
more extreme ratios given no copy number changes, we need to know the null
distribution of read count ratios in two genomes without any CNV. To obtain
the null distribution of read count ratios, we need to know the distribution of
read counts in a sliding window in each genome.
In shotgun sequencing, each sequencing read is randomly sampled across
the genome. Therefore, the number of reads in a sliding window is approxi-
mately distributed according to Poisson distribution, Po(λ), which is the dis-
tribution of number of random events occurring in a fixed time period. The
Poisson distribution is defined by the mean number of reads in a sliding win-
dows, λ, which is dependent on the total number of reads sampled, the length




where N is the total number of sequenced reads, G is the size of the genome
and W is the size of the sliding window, and W <<G . A Poisson distribution
can be approximated by a Gaussian distribution with continuity correction
when λ> 10. The ratio distribution of two Poisson distributed variables is not
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known; therefore, in order to determine the distribution of read count ratios
we use the Gaussian distribution to approximate the Poisson distribution with
mean and variance λ=µ=σ2.
2.2.3 Distribution of Read Count Ratios
Knowing the distribution of read counts in a sliding window of the two genomes,
X and Y , we can calculate the ratio distribution of two read counts, pz(z)=
pz(X /Y ). This distribution is given by Gaussian ratio distribution (Hinkley,
1969):































































The computation of this distribution is cumbersome, but it can be trans-
formed to another variable, t , by the Geary-Hinkley transformation (Hayya
et al., 1975):




where µX , σ2X , µY and σ
2
Y are the means and the variances for X and Y respec-
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tively. The new variable t approximates to a standard Gaussian distribution
when the mean number of reads per window is greater than 6 in Y and less
than 40,000 in X (Hayya et al., 1975).
2.2.4 p-values of Copy Number Ratios
We can then convert the observed read count ratio z to DNA copy number
ratio r in each sliding window by
r = z× NY
NX
(2.8)
where z is the ratio of read counts in the window and NX and NY are the
total number of reads in the genomes X and Y respectively. After obtaining
the distribution of z by equation 2.7, we can calculate the p-value of a copy
number ratio r , or the probability of obtaining a copy number ratio r or more
divergent from 1:1 ratio by random chance, by
p =

2× (1−Φ(t )) if r ≥ 1,
2×Φ(t ) if r < 1.
(2.9)
where Φ(t ) is the cumulative standard Gaussian distribution function as shown
in Equation 2.6 on the preceding page.
2.2.5 Calculating Parameters for CNV-seq
The above equations establish the connections between the total number
of reads (NX and NY ), genome size (G), sliding window size (W ), and the
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copy number ratios (r ) with its p-values. Based on the connections, we could
calculate various parameters in CNV-seq.
2.2.5.1 Minimum window size
According to Equation 2.9, the p-value decreases with increasing sliding win-
dow size (Figure 2.2 on the next page) and we would like p to be as low as
possible. Conversely, increasing sliding window size leads to decreasing resolu-
tion of CNV detection. Therefore it is advantageous to compute the minimum
window size that can be used to reliably detect CNV, according to a preset
threshold of p for r .
Based on the above equations, We can calculate the theoretical minimum
window size, W by
W = (NX r
′2+NY )GT 2





Φ−1(1−0.5×p ′) for detecting CNV with ratio ≥ r ′,
Φ−1(0.5×p ′) for detecting CNV with ratio ≤ r ′.
(2.11)
where p ′ is the desired significance level, and r ′ is the CNV detection threshold
ratio. Φ−1 is the inverse function of Φ. The number of reads sampled will affect
the minimum window size (Figure 2.3 on page 53). For example, if one wants
to detect CNV with ratio ≥ 3 : 2 at significance level 0.002, a genome size of 3G
bases and 10M reads in both genomes will yield the minimum window size of
37,243 bases, while 1M reads will yield the window size of 372,431 bases. The
use of larger number of reads allows detection of ten times shorter CNV.






















Figure 2.2: Dependencies of p in CNV-seq. The relation of p
and sliding window size is shown on 0.2X to 5X sequence cov-
erage for log2(r
′)= 0.6 and average read length 50 bases. The
coverage is the number of nucleotides sequenced divided by
the total number of nucleotides in a genome. The values are
computed using equation (2.9). Increased window length re-
sults in decreased probability, p of observing ratio r ′ or higher
by sheer chance. It is possible to compensate lack of cover-
age by increasing the window size, but this results in lowering
the resolution (see next figure for variation of window size vs
coverage).
























Figure 2.3: Dependencies of theoretical minimum window
size in CNV-seq. The relation of window size with sequencing
coverage and p-value is shown for log2(r
′)= 0.6 and average
read length 50 bases. The values are computed using equation
(2.13).
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2.2.5.2 Minimum window size measured by number of reads
Due to varied complexities across a genome, different regions of the genome
often have varied number of mapped reads. The regions with large number
of mapped reads should allow the usage of a smaller window than a region of
the same size but with fewer mapped reads. One approach is to use dynamic
window size, determined by the number of mapped reads in each window.
Similarly to Equation 2.10, we can calculate the minimum mapped read counts
in a flexible window for genome X and Y , CX and CY :









Based on Equation 2.12 and 2.13, when NX =NY , the minimum mapped
reads required in a sliding window are only determined by r ′ and p ′ (Figure
2.4).
2.2.5.3 Detectable copy number ratios
An alternative approach of using CNV-seq is to calculate the range of copy
number ratios that can be detected at a certain significance level p ′, with a
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Figure 2.4: Dependencies of theoretical minimum mapped
reads required in a sliding window in CNV-seq. The relation of
window size defined by mapped read counts with p-value and
log2(r
′) is shown. The values are computed using Equation
2.12 and 2.11.
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Figure 2.5: The minimum detectable copy number gains
given a predefined sliding window size and p-value is shown.
The values are computed using Equation 2.14.
where









2.2.5.4 Length of sequencing reads
One interesting aspect of the above equations is that, the length of sequencing
reads is not involved in the performance and parameter calculation in CNV-
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seq. The key factor determining the performance of CNV-seq is the number
of mapped sequencing reads, and this makes CNV-seq suitable to use with
the Next Generation sequencing technologies, which usually produce massive
amount of short reads.
2.3 Discussion
We have developed a robust statistical model, which gives a framework for CNV
detection by sequencing. Our implementation of the method, CNV-seq com-
bines the advantages of microarray methods and high-throughput sequencing,
allows confidence assessment and the calculation of various important param-
eters.
We expect the continued rapid development of sequencing technologies to
further lower the cost and increase the speed of sequencing. Thus, sequencing-
based approaches are likely to gain increased advantage over microarrays. Next-
generation sequencing methods mostly produce a large number of short reads
and our results show that the number of reads sequenced - not the length of
the reads, is the most important factor that determines the resolution, i.e. larger
number of sequenced fragments results in increased resolution, as long as the
reads are long enough for mapping. Alternatively, given a constant resolution
an increase in the number of sequenced reads will result in increased sensitivity
and specificity. Therefore, a large number of short reads is an advantage as
opposed to a small number of long reads. With the quick emerging of new
generation of sequencing technologies, CNV-seq will be increasingly useful for
CNV detection using sequencing data.
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A suite of computational tools for CNV-seq were implemented, and the
performance of CNV-seq is tested in the next chapter using simulated data.
3
Validation of CNV-seq using
Simulated Data
3.1 Introduction
In the previous chapter, we have described a new method for detecting DNA
copy number variation (CNV) using high-throughput sequencing data, CNV-
seq. In this chapter, we describe the performance assessment of the CNV-seq
model using simulated data.
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3.2 Materials and Methods
3.2.1 Implementation of CNV-seq
The computational tools are implemented using programming language Perl
(Wall et al., 2000) and R (R Development Core Team, 2009). Shotgun sequenc-
ing reads are mapped to a template genome assembly by BLAT (Kent, 2002)
or MAQ (Li et al., 2008) depending on read length. Best hit locations for each
mapped sequencing read are extracted from the BLAT or MAQ output by a Perl
script best.hit.pl. The best hit locations are then fed to another Perl script
cnv-seq.pl, which utilizes our R package cnv to calculate parameters and as-
sess confidence values for detected CNVs. The complete package is available at
http://tiger.dbs.nus.edu.sg/CNV-seq. The manual of the CNV-seq tools
can be found in Appendix A.
3.2.2 Simulation of Genomes with Different CNVs
The human chromosome 1 (NCBI build 36) was used to construct one diploid
reference genome and 100 diploid test genomes. The unmodified chromosome
1 sequence was used as the template genome. The test individual genomes are
constructed by the introducing CNVs, SNPs and short indels. The CNVs are
introduced into each of the test genomes by concatenating the two chromo-
somes and by selecting nine source sequences at random positions to replace
26 target sequences at random positions. Four of the nine source sequences
are used four times each to replace four random target sequences and the
remaining five of the nine sequences are used to replace two random target
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sequences each. The procedure results in the total of 35 segments in each of
the 100 simulated test genomes with the following copy number ratios: 26 with
ratio 1:2, five with ratio 4:2 and four with ratio 6:2. The length of the source
sequences is 10k , where k is a random number between log10 500 and log10 2M,
yielding the median length of 26,464 bases and the mean 234,065.7 bases. In
addition, each test genome is modified by randomly introducing 5 SNPs per
Kb and short, 1–3 bp insertions/deletions with the frequency of 0.5 indels/Kb.
The whole simulation process was performed by our customized scripts.
The reference or control genome is constructed the same way as the indi-
vidual test genomes, except no CNV was introduced.
3.2.3 Simulation of Shotgun Sequencing
We simulated the shotgun sequencing process for test and reference genomes
by using real sequence quality files, specific for each sequencing method. The
quality files used for Sanger and 454 sequencing were downloaded from the
personal genome projects of Venter (Levy et al., 2007) and Watson (Wheeler
et al., 2008) in Trace Archive (Wheeler et al., 2008), respectively. For the simula-
tion of Illumina method we used quality files from the project SRA000261 in
Trace Archive (Chen et al., 2008). The lengths of the quality files define the read
lengths at a random starting position. The errors were introduced according
to quality values given in the quality files. Both Sanger and 454 methods use
Phred quality values , q and the error probabilities, e are given by e = 10q/−10
(Ewing and Green, 1998). The errors are introduced by generating a random
number R between 0 and 1. If R < e, then one of the following errors will be
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introduced: substitution to one of the three remaining bases, an insertion or
a deletion. The probability of an indel is 10% of all introduced errors with
the equal ratio of indels. The base frequency in the source genome is used to
calculate the frequency of each base, which is in turn used to give the insertion
and substitution probability. The Illumina quality values, qs can be converted
to Phred quality scores as follows
q = 10× log10(1+10qs /10) (3.1)
We simulated the shotgun process for 0.1×, 0.2×, 0.5×, 1×, 2×, 5×, and
8×coverages.
3.2.4 The Performance of CNV-seq
The performance is measured by counting the number of sliding windows
giving a correct or alternatively an incorrect prediction. Our model describes
the theoretical limit of detection for given data with given r ′ and p ′. The true
copy number ratio of each window is known in the simulated data, i.e. the true
r. All windows where true r ≥ r ′ or r ≤ 1/r ′ should be classified as CNV in order
to achieve 100% sensitivity. Similarly, all windows where true r ≤ r ′ or r ≥ 1/r ′




Using the human chromosome 1 as template, a total of 101 genomes were
constructed: 100 testing genomes and one reference control genome, con-
taining varied numbers, sizes and locations of CNV regions, SNPs and short
insertions/deletions. It is obvious that larger CNV regions are easier to detect
compared with smaller CNV regions, therefore we introduced a large number
of short CNV regions in our simulated data (Figure 3.1). We simulated three
sequencing methods, Illumina, 454 and Sanger for each constructed genome
on 0.1× to 8× coverage. This resulted in the total of 8,400 simulations.
3.3.2 Performance of CNV-seq
The results of the simulations on varied coverage with parameter p ′ = 10−4 and
log2(r
′)= 0.6 are shown in Figure 3.2. Each circle represents one simulation
— the x- and y-axis represent their sensitivity and specificity. The size of the
circles represent the window size used in the calculation. The window size
used is the theoretical minimum window size calculated based on equation
(2.10) given the parameter threshold p ′ and r ′. The median of sensitivity and
specificity for all simulations are 0.902 and 0.997.
The mean sequence length is dependent on the technology simulated.
Thus, in order to reach the same coverage, a larger number of fragments need
to be sequenced when sequencing is performed with Illumina, which produces
shorter reads than Sanger and 454 methods. According to our model, the largest
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Figure 3.1: The length distribution of copy number variable
regions in the simulated data
number of reads yields the shortest length of the sliding window and thus the
best resolution. The range of window sizes in our simulations varies from
1,103 bases to 2,951,792 bases, decreasing with increasing average sequencing
coverage. The results show that our model performs well in the presence of
errors. Despite increased resolution due to shortening of the sliding window
size, the sensitivity is increased together with increased sequencing coverage
(Figure 3.2).
Slight drop in specificity with increasing sequencing coverage can be ob-
served in Illumina data (Figure 3.2). This is likely to be due to SNPs, short
























































Figure 3.2: Performance of CNV-seq. The performance of
CNV-seq on data simulating Sanger, 454, and Solexa (Illumina)
methods (top strip). Results are shown for 0.2X–1X cover-
ages (right strip) with p ′ threshold setting at10−4 and log2(r ′)
threshold at 0.6. Each black circle represents one simulation
and the size of the circle represents the log10 value of window
size used, which are the theoretical minimum window sizes,
calculated using equation (2.10). The red marginal Box-and-
Whisker plots show summary of the sensitivity and specificity
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Figure 3.3: Specificity vs window size shown in the Box-and-
Whisker plot. In order to increase specificity, a window larger
than the theoretical minimum size can be used. The specificity
using 1x, 1.5x, 2x, 3x, 4x, and 5x of the theoretical minimum
window size are shown, for simulated Illumina sequencing
data at 8X coverage.
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model and have a more profound effect on small windows than large windows.
The specificity does not drop in error free data based on separate simulations.
The effect of errors may be reduced by using a window size that is larger than
the theoretical minimum. For example, the theoretical minimum window for
8× Illumina sequencing at p = 0.001 is 1947 bases. This window size gives a
specificity of 0.954, while a 2 times larger window yields specificity of 0.978
(Figure 3.3).
3.4 Discussion
The performance of CNV-seq model was tested using simulated sequencing
data. Various sequencing technologies — Sanger, 454, and Illumina, were simu-
lated. The theoretical minimum window size is used for 8,400 sets of simulated
data sets, with various sequencing coverage and parameter thresholds for p ′
and r ′.
Overall CNV-seq achieves very high specificity and sensitivity, showing that
our statistical model for CNV-seq works as expected. Illumina can produce the
smallest window size while maintaining comparable or better sensitivity and
specificity, thanks to its shorter reads than Sanger and 454. This shows that the
number of mapped sequencing reads is the most important factor in CNV-seq,
while the length of the reads is not.
Our statistical model considers the variation of sequencing coverage in
shotgun sequencing process and effects of other factors, such as sequencing
errors and mapping errors, are minimized by taking ratios of two sets of data.
However, those effects cannot be removed completely — as we can see, the
3.4 DISCUSSION 68
specificity slightly drops with increasing coverage (leading to decreasing mini-
mum window size) in Illumina data due to SNPs, short indels, and mapping
errors which are not computed in our statistical model. However, this speci-
ficity drop problem can be solved by using a larger window than the theoretical
minimum.
4
Detection of CNV Between Two
Human Individuals
4.1 Background
As the sequencing technologies develop, an increasing number of human
personal genomes are sequenced. The first personal genome was Venter’s
genome published in 2007 by Levy et al.. The second one was Watson’s genome,
published one year later (Wheeler et al., 2008). Then several other personal
genomes followed closely (Bentley et al., 2008; Wang et al., 2008; Ley et al.,
2008; Ahn et al., 2009). More excitingly, the 1000 Genomes Project aims to
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sequence 1,000 volunteers (Kuehn, 2008; Siva, 2008; Wise, 2008), indicating the
potential of CNV-seq. In this chapter, we will apply CNV-seq on the first two
personal genomes.
4.2 Materials and Methods
4.2.1 CNV-seq on Venter’s and Watson’s Genomes
The shotgun sequencing data were downloaded from the personal genome
projects of Venter and Watson in Trace Archive. The template genome was
downloaded from Ensembl (Birney et al., 2004), human genome assembly,
NCBI Build 36. The sequencing reads were mapped to the assembly using
BLAT program with default parameters (Kent, 2002). The CNV-seq thresh-
olds p ′ = 10−5 and log2(r ′) = 0.6 were used. Given the data these thresholds
yield the window size of 44,460 bases for autosomal chromosomes, 1,656,781
bases for chromosome X and 7,093,111 bases for chromosome Y. Multiple
testing was corrected by Bonferroni correction. The distribution of GC frequen-
cies in sequencing reads from Venter and Watson data are examined using
Kolmogorov-Smirnov test.
4.2.2 Comparison with CNV Detected by aCGH
CNV regions detected by aCGH in Venter’s and Watson’s genomes were ob-
tained from Levy et al. (2007) and Wheeler et al. (2008) respectively. Two CNV
regions with overlapping of more than half of their length are considered over-
lapped.
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4.2.3 Comparison with Previously Known CNV in DGV
Previously known CNV regions reported in Database of Genomic Variants
(DGV) (Iafrate et al., 2004) were used to assess the significance of our CNV
calls. The number of overlapping CNV regions between CNV-seq calls and
DGV data set is calculated the same way as in section 4.2.2. This number is
compared to a null distribution where all CNV calls are random calls to test for
significance. The null distribution was generated by 5,000 sets of permutation
tests where the same number and sizes of random CNV calls as real CNV calls
by CNV-seq are compared to DGV data. The p value is calculated by comparing
CNV-seq calls with the permuted distribution.
4.2.4 Over- and Under-represented Gene Ontology Categories
Gene Ontology (GO) categories over- and under-represented in the genes
located in the CNV regions are identified using the GOStat server at http:
//gostat.wehi.edu.au/ (Beissbarth and Speed, 2004). Minimal length of con-
sidered GO paths is three. p-value threshold for over- and under-representation
is set to 0.01. Multiple comparisons are corrected with Benjamini method us-
ing False Discovery Rate. When both parent and child categories in the GO
hierarchy are over-represented, only the child GO category is reported.
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4.3 Results
4.3.1 Overview of CNVs Detected
We compared two of the first personal genomes, Dr. Craig J. Venter and Dr.
J. Watson. The sequence coverages were 7.5× and 7.4× coverage respectively
(Levy et al., 2007; Wheeler et al., 2008). The genome of Dr. Craig J. Venter
is sequenced using Sanger method and Dr. J. Watson’s genome using 454
technology. We compared the two genomes using CNV-seq (Figure 4.1). The
thresholds p ′ = 10−5 and log2(r ′)= 0.6 yield sliding window size of 44,460 bases
for autosomal chromosomes. The sex chromosomes have a lower sequencing
coverage than autosomal chromosomes, therefore larger window sizes are used:
1,656,781 bases for chromosome X and 7,093,111 bases for chromosome Y. We
identified 73 contiguous regions covered by four or more consecutive windows,
covering 0.4% of the genome (Appendix C). The sizes of these regions range
from 88,920 bases to 4,857,255 bases, with median and mean size of 216,742
and 232,806 bases respectively. After considering the consecutive windows
and multiple testing correction (Bonferroni correction), the effective p-value
threshold for the 73 CNV regions is 1.04×10−15.
A major assumption in CNV-seq is that shotgun sampling of DNA fragments
is random, and therefore the CNV calls made by CNV-seq are not due to differ-
ent sequencing bias between the two sets of data compared. When the two sets
of data are prepared in the same way, this assumption is valid. However, when
the shotgun sequences are generated using two different sequencing methods,
the assumption may not hold any more. Illumina sequencing reads are recently
reported to be GC-biased dependent on a library preparation procedure (Quail
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Figure 4.1: Copy number variation detected by CNV-seq us-
ing shotgun sequence data from two individuals, Venter and
Watson (Levy et al., 2007; Wheeler et al., 2008). The top panel
shows a genome level log2 ratio plot. The middle panel shows
the plot for chromosome 10. The bottom panel shows detailed
view of a CNV region in chromosome 10. The red color gra-
dient in the middle and bottom sections represents log10(p)
calculated on each of ratios.
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et al., 2008). Venter’s genome was sequenced using Roche’s 454 Pyrosequencer
and Watson’s genome was sequenced using the Sanger method. We compared
the distribution of GC frequencies in the shotgun reads in both genomes. No
significant differences were detected between the two distributions (p = 0.210,
Kolmogorov-Smirnov test). Other potential technology-specific problems in
sequencing are not considered. For example, 454 sequencing is known to have
problem with mononucleotide repeats.
4.3.2 Comparison with Previously Known CNVs
The comparison of the 73 CNV calls with those in the Database of Genomic
Variants (DGV) (Iafrate et al., 2004) revealed 67 of the CNV calls to overlap with
previously reported CNV regions for more than half of their length. In order to
assess the significance of our CNV calls, we performed 5,000 permutation tests,
using 73 randomly distributed CNV regions of the same sizes as in the original
experiment. Only average of 25.7 and maximum of 41 permuted regions over-
lap with CNV in DGV for more than half of their length (Figure 4.2). The real
CNV calls have significantly more overlapping regions with DGV (p-value = 0).
4.3.3 Comparison with CNVs Detected by aCGH
We also intersected the CNV calls with the CNVs identified by aCGH in the two
genomes. There are 23 and 45 CNV regions reported in Watson’s and Venter’s
genome respectively (Levy et al., 2007; Wheeler et al., 2008). We found 15 of
our CNV calls to overlap with 10 of previously reported Watson’s CNV regions,
and only 11 of our CNV calls to overlap with 5 of Venter’s. The low number
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Figure 4.2: A permutation test was performed in order to test
the significance of our CNV calls. The histogram shows the
number of CNV calls overlapping with CNV in DGV. The X-axis
shows the number of calls overlapping with DGV. The Y-axis
shows the frequency of the overlapping number in 5,000 sets
of permuted CNV calls.
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of overlaps with Venter’s CNV calls made by aCGH is not surprising, for the
reason that the majority of the CNV regions were detected by only one of three
microarray platforms (Levy et al., 2007). There are 32 CNV calls that made by
CNV-seq not overlapping with aCGH but overlap with DGV data, suggesting
that CNV-seq can detect CNV regions that were missed by aCGH. One of these
regions is shown in Figure 4.1 (bottom panel), a 238 Kb region (copy number
ratio 6:1, p = 0) containing two genes (FAM23B, MRC1L1) and one miRNA
(hsa-mir-511-2). We have used stringent thresholds in our analysis, thus by
lowering thresholds, such as p-value and the number of consecutive windows,
will increase the number of reported CNV calls.
4.3.4 Genes in the CNV Regions
Based on the size of the detected CNV regions, we would expect 212 genes to
be covered by the CNVs. However, only 149 genes are located in the detected
CNV regions (see Appendix C.4 for a full list), which is significantly lower
than expected (p = 1.4× 10−5, Chi-squared test). Based on Gene Ontology
enrichment analysis, genes from two biological processes are over-represented
in the 149 genes, as shown in Table 4.1. The most over-represented GO is
GO:0042742, or genes involved in immune defense response to bacterium (8
of 115 genes, p = 1.58×10−7). The other one is α-amylase genes, with 2 of the
5 α-amylases locating in the CNV regions (p = 0.00185). No GO in terms of
biological processes or molecular functions are found to be significantly under-
represented. However, in term of cellular components, intracellular part genes
are significantly under-represented (p = 1.29× 10−5). Both genes encoding
cytoplasm proteins and intracellular organelles are under-represented.
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GO Description p-value Over-/Under-
GO:0042742 defense response to bacterium 1.58e-07 over
GO:0004556 α-amylase activity 0.00185 over
GO:0044424 intracellular part 1.29e-05 under
GO:0005737 cytoplasm 0.00459 under
GO:0043226 organelle 1.68e-05 under
Table 4.1: Over- and under-represented Gene Ontology terms
in the CNV regions, calculated by the GOStat server. p-value
threshold is 0.01. Multiple comparison is corrected using Ben-
jamini method.
Some of the genes are known to be commonly found with variable copy
numbers, such as the salivary amylase gene (AMY1) (Perry et al., 2007; Hastings
et al., 2009). AMY1 is the enzyme responsible for starch hydrolysis. Perry et al.
(2007) found that there are significantly larger copy number of AMY1 gene
in population with high-starch diets than those with traditional low-starch
diets. Another example is the genes encoding complement factor H related
3 (CFHR3) and 1 (CFHR1). Deletions of the two CFHR genes are reported to
account for a portion of the protection from age-related macular degeneration
(AMD) (Spencer et al., 2008; Schmid-Kubista et al., 2009).
4.4 Discussion
In previous chapter, we tested CNV-seq with simulated data, which allowed
us to profile the performance knowing the nature of the simulated data. How-
ever, simulated data cannot replace testing with real data. In this chapter, we
described the application of the CNV-seq method on two recently sequenced
personal genomes, Venter’s and Watson’s. 174 CNV regions were detected be-
tween the two genomes, of which 142 regions overlap with known CNVs in
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DGV. The number of overlaps with known CNV regions is significantly higher
than with permuted random CNV calls (p = 0, permutation test), showing that
the CNV-seq method is performing well.
5
Hidden Markov Model Approach to
CNV-seq Data Analysis
5.1 Introduction
The CNV-seq method provides a robust statistical framework for CNV detec-
tion using sequencing data, however, there are still some unique features of
sequencing-based approach not utilized. For example, the higher dynamic
range and “digital” nature of sequencing-based approaches, in comparison
with the lower dynamic range and “analogue” nature of microarray-based
approaches, should be utilized to make more accurate copy number ratio
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estimation. Importantly, the resolution of CNV-seq is not limited by fixed mi-
croarray probes, therefore, it should be possible to detect CNV boundaries at
the resolution about the average distance between two adjacent reads mapped
to a genome template.
We developed a Hidden Markov Model approach to CNV-seq data analysis.
The approach will exploit the unique features of sequencing-based CNV-seq,
and yields increased accuracy of copy number ratio estimation and at the
highest possible resolution given a set of data.
5.1.1 Hidden Markov Model
Hidden Markov Model (HMM) is a statistical model first applied to speech
recognition in 1970s (Huang et al., 1990). The major task of HMM is to estimate
the sequence of hidden states in a system based on a sequence of observable
values. There are four types of parameters in a HMM — the hidden states,
the emission probabilities, the transition probabilities, and the initial state
distribution. A brief introduction on HMM can be found at Appendix D.
It is easy to model our CNV-seq problem with a simple Hidden Markov
Model — the hidden states are the DNA copy number ratios, while the ob-
served values are the sequencing read-count ratios. However, the resolution
for CNV detection in such a model is limited to the size or moving steps of
sliding windows, while the highest possible resolution in CNV-seq should be
the average distance between two adjacent sequencing reads. In this chapter
we will develop a two-stage HMM approach to achieve such high resolution
with low computing resource requirement.
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5.2 Results
We developed a two-stage Hidden Markov Model approach to the analysis of
CNV-seq data. The first stage will detect CNVs with high reliability and fast
computing, but with relatively low boundary resolution, using sequencing read-
count ratios in sliding windows. Then the second stage will determine the CNV
boundaries at the highest possible resolution, which is the average distance
of adjacent sequencing reads, using the information from every mapped read
around a candidate CNV boundary from the first stage.
5.2.1 Stage 1 — Detecting CNV Using Window-Based Data
Sliding window-based read count-ratios are used to build the first stage HMM.
There are two advantages for using window-based HMM in this stage. First the
computing speed is improved compared to individual-read based approach,
because there are fewer windows than individual reads in the system. Second,
the smoothing effect of counting by window can reduce the false positive rate
of CNV calling and the statistical model developed in Chapter 2 can then be
used to calculate reliable parameters for the sliding windows. The disadvantage
of window-based approach is that the resolution is sacrificed. Therefore we
need the second stage of HMM in which the resolution is increased.
The system to be modeled in the first stage is a series of sliding windows.
Each window has an associated DNA copy number ratio state, which is the
hidden states in HMM. The states changes along the genome, and the proba-
bilities of changing from one state to another state in two adjacent windows
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are the transition probabilities. If we know the current state of the system,
then the next state can be calculated using the transition probability. However,
the initial state of the system cannot be determined in this manner, because
there is no previous state before that. Therefore, in a HMM we also need to
know the initial state distribution. What we are interested from the HMM is the
sequence of the hidden states in the system, which can tell us the DNA copy
number ratios along the genome. However, the states are hidden and thus not
observable in the data. Instead, we can observe the mapped read count-ratio
for each window, which is the emitted value in HMM. The conditional proba-
bility of observing a certain read count-ratio when the system is in a certain
hidden state is the emission probabilities. Therefore we need to specify the
four types of parameters for our first stage HMM.
5.2.1.1 Hidden States
The first things to define in a HMM are the hidden states, S, which are given
by
S = S1,S2, . . . ,SK (5.1)
where K is the number of states in the model. The hidden states in our HMM
are the DNA copy number ratios in sliding windows. The parameter K is es-
timated from the range of the observed values — read-count ratios, given
by
K = b2max(| log2 r |)+1c×2−3 (5.2)
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where r is normalized read-count ratios in sliding windows. The DNA copy
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For example, if the most extreme read-count ratio is 52 or
2
5 , then using Equa-
tion 5.2 we can calculate the number of hidden states, K = 7. Using Equation





















Copy number ratios of 0n or
n
0 have to be treated specially, e.g., replacing
0
n with a very small ratio and replacing
n
0 with a very large ratio in the hidden
states solves the numerical problem. The replacement values can be calcu-
lated from existing data. For example, 0n can be replaced by the smallest copy
number ratios in all windows.
The main aim of the Hidden Markov Model is to find the most probable
path of the hidden states in a system, s, where si is the copy number ratio state
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in i -th window in our system.
5.2.1.2 Emission Probabilities
Emission probabilities are the set of probability density functions representing
the probability of observing value b when the system is in hidden state k, given
by
ek (b)= P (xi = b|si = k) (5.7)
In our model, the observed values, b, are the log2 ratios of read counts in
each of the sliding windows. The read-counts are distributed according to
Poisson distribution with mean λ. The distribution of the ratios of two Poisson
variables are not known, but can be approximated by a log-normal distribution
(Rola and Pelat, 1994). Therefore, the emission probabilities of the log2 read-
count ratios are defined based on Normal distribution. The mean and the





using the R package MASS by Venables and Ripley (2002), where the function
pois(x) is the Poisson random number generator with mean of x.
It has been shown that the emission probabilities are the most critical
parameters in HMM, while the initial state distribution and state transition
probabilities the accuracy are not as important to the model performance
(Rabiner, 1989; Fridlyand et al., 2004). Since the relative number of mapped
reads is directly proportional to the relative copy number of a DNA segment
in CNV-seq, we can accurately estimate the emission probabilities for each
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copy number ratio state. This is an advantage compared to aCGH, where the
fluorescent intensities are not linearly proportional to the DNA copy numbers
due to the limited dynamic range in microarrays.
5.2.1.3 Transition Probabilities
Transition probability is the probability of changing to state l from previous
state k, given by
akl = P (si = l |si−1 = k) (5.9)
Our model, gives high transition probability to transitions from copy number
varied states to normal state, while the probability is low for the reverse. The
assumption is that a large portion of the genomes contain normal copy num-
bers, therefore there are more normal states than copy number varied states
in the system. Since there are K states based on last section, the transition
probability is a matrix, A, with dimension of K ×K , where Ai j is the transition
probability from state Si to state S j .
The transition probabilities between CNV states vary in different genomes.
Most notably, the transition probability between two different CNV states is
much higher in a tumor–normal tissue comparison than normal–normal com-
parison. Therefore, different sets of initial transition probabilities should be
set for CNV detection involving tumor genomes to reflect the high probability
of copy number changes.
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5.2.1.4 Initial State Distribution
The transition probability (Equation 5.9) cannot be used to estimate the initial
state of a system, because there is no previous state for it. Therefore, we need
to provide the initial state distribution of a HMM, given by
pii = P (s1 = Si ) (5.10)
or the probability that the first state in the system, s1 to be state Si . Using
the same assumption that most parts of the genomes contain normal copy
numbers, we give more weight to the normal copy number ratio state in this
distribution.
5.2.1.5 Most Probable Sequence of CNV States
Given the above parameters, the Viterbi algorithm can be used to find the most
probable sequence of DNA copy number ratio states (Viterbi, 1967), and thus
the CNV regions can be detected. However, the resolution of the detected CNV
regions are limited by the size of the moving step of sliding windows, while the
highest possible resolution for CNV-seq data should be the distance between
two mapped reads. This resolution could theoretically reach single nucleotide
level, when the number of reads is equal to the size of the genome, or when
the sequencing coverage is equal to the read length.
Simply reducing the moving step of the sliding windows will not solve the
resolution problem, because the window-based ratios are smoothed for each
window and small moving step will only make increase the ambiguity of state
transition. Therefore, we developed the second stage Hidden Markov Model.
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5.2.2 Stage 2 — Resolving CNV Boundaries Using Information
from Individual Reads
The low-resolution locations of CNV region boundaries detected in the first
stage HMM are examined separately using the information of individual reads
mapped around the candidate boundary. The focused approach allows us to
achieve highest possible resolution while keeping computing requirement low
by not examining all reads sequenced.
5.2.2.1 Hidden States
Unlike the first stage HMM, where CNV states for the whole chromosomes are
studied at once, in the second stage HMM, we examine each CNV boundary
individually. There are two states in each model in this stage. Each CNV bound-
ary is a transition between two different DNA copy number ratio states, A and
B . Both state A and B are members of the hidden states that we described in
Equation 5.3 and 5.6. The identities of the two states are given by the first stage
HMM. To ensure that our model always starts with state A and ends with state
B , we introduce a special end state, E , which always occurs as the last state of
a system (Figure 5.1).
5.2.2.2 Emission Probabilities
The observed values in this stage are the individual mapped reads. Both state
A and B can emit reads from both genomes compared, X and Y , with different















Figure 5.1: The second stage Hidden Markov Model. There are
three hidden states in the second stage HMM for each CNV
boundary. The state A and B are the DNA copy number ratio
states at the two sides of the CNV boundary. The state E is a
special end state to make sure the model ends with state B .
State A and B emit sequencing reads from either of the two
tested genomes, x or y , based on their underlying DNA copy
number ratios. Variable z is expected read-count ratio in a
state before normalization.
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are x and y , the emission probabilities for emitting the values when the system








where zs is the expected reads-count ratio in state S without normalization,
given by
zs = rs × NX
NY
(5.13)
where rs is the DNA copy number ratio in state S, while NX and NY are the total
number of reads from the two genomes mapped on the whole chromosome or
genome.
For the reason that we introduced a special end state E , in addition to
the observed reads x and y , a special read e should be appended at the end
of the read sequence. State E emits the special value e only, therefore, the
probability for state E emitting e is 1, and the probabilities of emitting x or y
are 0. Similarly, the probabilities for state A and B emitting the special value e
are 0 too. The distribution of emission probabilities is illustrated in Figure 5.1.
5.2.2.3 Initial State Distribution
The initial state distribution in the second stage is much simpler than in the
first stage. The only possible initial state is the state A, as determined by the











E 0 0 0
Table 5.1: Transition probabilities in the second stage HMM.
The number or formula in table cell (k, l ) represents the tran-
sition probability between state k and l . The variable na and
nb are the estimated number of reads in state A and B respec-
tively, based on the first stage HMM.
probability of A to be 1, as shown in the following equation:
pik =

1, k = A
0, k =B
0, k = E
(5.14)
where pik is the probability of the initial state to be k.
5.2.2.4 Transition Probabilities
Unlike the first stage HMM, where transition between any two hidden states
are possible, in the second stage the initial state A can only change to itself
or state B , and state B can only change to itself or the end state E , while the
special state E cannot change to any state. The equations for calculating the
transition probabilities, ekl , are shown in Table 5.1.
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5.2.2.5 Resolving CNV Boundaries at High Resolution
To resolve each potential CNV boundary, all reads that are mapped nearby will
be extracted and sorted based on their mapped locations. A special end symbol
will be appended as the last mapped reads. The second stage HMM can be
used to determine the CNV boundaries utilizing the Viterbi algorithm (Viterbi,
1967). The resolution for the boundaries is the average distance between two
adjacent mapped reads.
5.3 Summary
In order to accurately detect CNV locations and high-resolution boundaries
from CNV-seq data, we developed a two-stage Hidden Markov Model approach.
This is the first method to fully utilize information in each individual mapped
read for high resolution CNV boundary detection.
The first stage model will use window based read-count ratio data to deter-
mine the existence of CNV in a low-resolution location. The use of window-
based data in the first stage has two advantages. First, the window size cal-
culated using the CNV-seq statistical model (Chapter 2) means that the CNV
regions detected are highly reliable. Second, computing requirement is kept
low for whole genome analysis by not examining each individual read.
The second stage HMM resolves the CNV boundaries at highest possible
resolution based on the candidate boundaries detected by the first stage HMM.
Each individual mapped read around each potential boundary are considered
and the most probable boundary locations are determined by the Viterbi algo-
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rithm. The resolution achieved is the average distance between two adjacently
mapped reads. By increasing the number of reads, it is possible to reach single
nucleotide resolution. Because every individual sequencing read is considered,
the potential computing load for a large system is very heavy. However, by us-
ing the two-stage approach, only the reads around potential CNV boundaries
are considered, therefore the amount of computing is reduced.
None of the two stages can be used alone to achieve the high-resolution
and keep low false-positive rate. For example, to use the first stage alone, the
moving steps must be as small as the distance between two adjacent reads. This
means that any two adjacent windows will share identical composition except
a single read, whose effect will be smoothed out by the large number of shared
reads, resulting in ambiguous transition between two states at the boundary,
thus making high resolution boundary detection impossible. In addition, the
transition probability in the HMM approach will be highly unreliable due to
the high level of overlap.
In the two-stage approach, we only need to consider individual reads
around a potential CNV boundary, and we only need to consider two DNA
copy number ratio states in each of the models. The identity and sequence of
the two states are reliable because they are derived from a larger picture of the
system using window-based data from the first state. This not only improves
computing speed, but also reduces the false discovery rate.
6
Performance of the HMM Approach
6.1 Introduction
We have developed a two-stage Hidden Markov Model approach to reliably
detect CNV regions and resolve CNV boundaries. The expected resolution in
the HMM approach is the average distance between two adjacently mapped
sequencing reads, which is the highest possible theoretical resolution.
In this chapter, we assess the performance of the two-stage HMM approach
using simulated data. For the first stage, we focus on testing false discovery rate,
because the major task of the first stage is to identify potential CNV regions
93
6.2 MATERIAL AND METHODS 94
with high confidence. For the second stage, we focus on testing the accuracy
of the calculated CNV boundaries, which is the major task of the second stage.
6.2 Material and Methods
6.2.1 Implementation of the HMM Approach
The HMM approach is implemented as an extension to CNV-seq, and pack-
aged in CNV-segHMM, using programming language Perl (Wall et al., 2000)
and R (R Development Core Team, 2009). The HMMs in both stages are im-
plemented using the RHmm package in R (http://cran.r-project.org/web/
packages/RHmm/). The manual of the CNV-segHMM can be found in Ap-
pendix A. The complete package can be found at http://code.google.com/
p/cnv-seghmm.
6.2.2 Simulated Data
The 101 simulated genomes described in Section 3.2.2 are used — 100 test
genomes and one common reference genome). The CNV regions introduced
in the test genomes are: 26 with ratio of 1:2, five with ratio of 4:2, and four
with ratio of 6:2. The length of the CNV regions are distributed according to
10k , where k is a random number between log10 200 and log10 2M, as shown in
Figure 3.1.
The reads were simulated using the simulate tool from the program MAQ
(Li et al., 2008). Real Illumina sequencing data, SRR002794, from NCBI Short
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Read Archive are used to train the parameters for MAQ simulation (Wheeler
et al., 2008). Illumina reads are simulated for each simulated genomes at ap-
proximately 0.3× coverage, with the quality equivalent to real sequencing data.
Then the map tool from MAQ was used to map the simulated reads to
the template genome assembly, human chromosome 1. The best hits were
extracted and used as input for the CNV-segHMM.
6.2.3 Sensitivity and Positive Predictive Value of Detecting CNV
Regions
The results of the first stage HMM are the rough locations of putative CNV
regions. The reported regions are classified as true positives if they overlap
with the real CNV regions by more than half of their lengths. Otherwise, they
are classified as false positives. Similarly, real CNV regions in the simulated
data are classified as correctly detected if they overlap with reported regions
by more than half of their lengths.
The sensitivity s is calculated as the portion of real CNV regions in the
simulated data that are correctly detected. The specificity is ambiguous in
the data because the number of true negatives is ambiguous. Therefore, we
calculated the Positive Predictive Value (PPV) as the portion of reported CNV
regions that are real CNV. The CNV regions in the centromere regions are
ignored in the calculation of sensitivity and PPV. Five of the 100 genomes
are not considered due to the high number of simulated CNV located in the
centromere region of the chromosome.
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6.2.4 Accuracy of Resolving CNV Boundaries
The option --refine in CNV-segHMM is used to calculate the boundaries of the
putative CNV regions from the first stage HMM. The differences between the
calculated boundaries and real boundaries in the simulated data are computed
and measured by the number of mapped reads.
6.2.5 CNV Detection in Bushmen Genomes
Illumina sequencing reads and their mapped positions on the reference assem-
bly are downloaded from ftp://badger.bx.psu.edu/hg18/bam/(Schuster
et al., 2010). The CNV-segHMM tool is used to detect CNV between two Bush-
men genomes.
6.3 Results
6.3.1 Sensitivity and Positive Predictive Value of the First Stage
Using 95 sets of simulated data, we tested the performance of the HMM ap-
proach. The Positive Predictive Value (PPV) of detecting a real CNV region
by the first stage is 100% — all 928 CNV regions reported in the 95 sets of
simulated genomes are true positive CNV regions.
The sensitivity of detecting real CNVs highly depends on the size distribu-
tion of simulated CNV regions — the smaller the CNVs the lower the sensitivity.
In our simulated data, we included much more small CNVs than large ones
(Figure 6.1). In contrast to the high PPV, the sensitivity is relatively low — with
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Figure 6.2: Sensitivity of the first stage HMM using the 95
sets of simulated data. Each Box-and-Whisker plot shows the
distribution of sensitivity when CNV region of certain sizes are
considered (as shown on the x-axis).
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mean value of 56.6% and median of 58.1% for CNVs with length 10 Kb or
greater (Figure 6.2). This is not surprising, because the 0.3× coverage of simu-
lated sequencing reads only allow window size of 33 Kb, which means shorter
CNV regions in our simulated data are not likely to be detected given the non-
extreme copy number ratios simulated. If only CNV regions longer than 50 Kb
are considered, the sensitivity increases to mean value of 72.2% and median of
73.3%, while keeping the PPV at 100% (Figure 6.2).
6.3.2 Accuracy of Resolving CNV Boundary in the Second Stage
After obtaining a list of putative CNV regions, the boundaries of those regions
are resolved by the second stage HMM using every individual mapped read
around those regions. The number of left and right boundaries in 1,856 that are
resolved in the second stage. In this data set, 4.2% of the left boundaries and
3.9% of the right boundaries are miss placed by more than 100 mapped reads
(reads from both genomes are counted together). Majority of the remaining
boundaries are miss-placed by fewer than 20 reads — 71.5% for the left and
71.7% for the right boundaries (Figure 6.3).
In addition, the second stage is also used to detect false positive CNV
regions reported by the first stage. The principle is that, if the reported CNV
regions are real, then the HMM in this stage should be able to resolve its
boundary reliably — the most probable state path should follow the theory
described in Section 5.2.2. However, if the calculated most probable state
path does not fit in the model, this suggests that the the putative CNV region
reported by the first stage is likely to be a false positive.
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Figure 6.3: Error distribution of CNV boundary resolving by
the second stage HMM. The x-axis represents the error of
resolved CNV boundaries, measured by number of reads miss-
placed. Positive value means miss placed to the right side of
the real boundary, while a negative value means miss placed
to the left side. The y-axis shows the frequency of the errors
in x-axis. The top panel shows the error distribution for left
boundaries, and the bottom panel shows the error distribution
for right boundaries.
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In order to test the ability of the second stage to detect false positive CNV
regions, we performed a permutation test. 928 random genomic regions are
used as candidate CNV regions for the second stage HMM. The random regions
have the same size and copy number states as the CNV candidates detected by
the first stage. 95.0%, or 928 of the 977 random regions are correctly classified
as non-CNV regions based on the above principle. In contrast, only 5.0% of
the CNV candidates from the first stage are classified as non-CNV. Therefore,
combining the two stages can improve the PPV of this HMM approach.
6.3.3 Comparing Boundary Accuracy with FreeC
Boeva et al. (2010) developed a method to detect CNV using sequencing data.
It runs in two modes, control-free and with-control. We compared the bound-
ary accuracy of our CNV-seqHMM with the two modes of FreeC, using the
simulated data described above. The boundary error distribution is shown in
Figure 6.4. CNV-segHMM is about ten times more accurate than FreeC, in term
of number of nucleotides the boundaries are miss placed.
6.3.4 CNV in Bushman Genomes
Recently Schuster et al. (2010) sequenced five genomes of hunter-gather peo-
ple in South Africa. Using the Illumina sequencing data, we detected CNVs
between two of the five genomes — the KB1 and ABT individuals. There are
913,090,958 and 255,351,579 mapped reads in the two individual genomes,
yielding average distance between adjacent reads of 2.56 bases. Given the per-
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Figure 6.4: Comparing boundary detection error between
FreeC and CNV-seqHMM.
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Figure 6.5: Permutation test of overlapping between random
CNV calls with known CNVs in DGV.
boundaries to be specified an accuracy of 51 bases, and 92% with accuracy of
128 bases.
We detected in total 3,125 CNV regions using the CNV-segHMM tool (Ap-
pendix E). 1,414 or 45.2% of these regions overlap with the known CNV regions
in the Database of Genomic Variants (DGV). In comparison, 1,000 sets of ran-
dom chosen regions with the same number and size of the 3,125 regions show
significantly lower (p-value = 0) overlapping with DGV — mean 878.5 and
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Figure 6.6: A 150 Kb detected CNV region on chromosome
1, from 222,144,162 to 222,294,386 nt. The estimated copy
number ratio is 3:1.
Ensembl ID Gene Name Description
ENSG00000188610 FAM72B Family with sequence similarity 72, member B
ENSG00000227205 RP5-1042I8.3 Known pseudogene
ENSG00000226446 RP5-1042I8.6 Known pseudogene
ENSG00000207149 AL596222.1 Novel microRNA
Table 6.1: Genes located in the 515 Kb CNV region.
Two CNV regions from chromosome 1 are shown here as examples. A 150
Kb region (located from 222,144,162 to 222,294,386 nt) is detected as a CNV
region with copy number ratio 3:1 (Figure 6.6). The refined boundaries for this
CNV agrees well with the change of relative density between the two individual
genomes (Figure 6.7). There is no known genes in this region.
The largest detected CNV region on chromosome 1 is about 515 Kb long
(Figure 6.8 and 6.9). Four genes can be found in this region including one
microRNA (Table 6.1). Two of the genes are pseudogenes and the other one is
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Figure 6.7: The density plots of the mapped reads around the
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Figure 6.8: The largest detected CNV region on chromosome
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Figure 6.9: The density plots of the mapped reads around the
detected boundaries of the 515 Kb CNV region.
6.4 Summary
We tested the performance of the two-stage Hidden Markov Model approach
to the analysis of CNV-seq data. The purpose of this approach is to reliably
detect DNA copy number regions and precisely resolve the boundaries around
the detected CNV regions.
Testing on simulated data shows that the HMM approach can achieve
98.8% PPV. The sensitivity depends on the size distribution of CNV regions. In
our simulated data, where the amount of sequencing reads allows minimum
window size of 12 Kb, the HMM approach achieves sensitivity above 90% for
CNV regions with size equal or longer than 10 Kb.
After passing the first stage result to the second stage models, majority of
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the CNV boundaries are placed within 20 sequencing reads away from the
real boundary positions. The underlying distance between detected and real
boundaries depends on the coverage of the sequencing data — 30× coverage
short reads with length of 30 nucleotide each will produce average single-
nucleotide resolution. Therefore, with the increasing speed and decreasing
cost of sequencing technologies, it is feasible to achieve single nucleotide




DNA copy number variations are an important class of genetic variation, which
is relatively new to genetic research in comparison with other variations such
as SNP (Conrad et al., 2009). The traditional method to detect CNV is to use
microarray-based Comparative Genomic Hybridization, which has been uti-
lized for over a decade (Lai et al., 2005). Microarray technology has revolu-
tionized the way that large-scale genomic research carried out. However, mi-
croarray technology has its limitations. Importantly, the dynamic range of
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signal detection is limited (Shendure, 2008) and the resolution of microarray
experiment is pre-determined by the probes on the array.
DNA sequencing technologies are developing very fast. Several new genera-
tion of technologies have emerged, most notably the 454, Illumina, and SOLiD
technologies, which enabled fast and cheap DNA sequencing while generating
massive amount of short reads (MacLean et al., 2009). Traditional applications
of microarrays are being replaced by sequencing-based approaches. For ex-
ample, the genome scale protein-DNA interaction detection tool ChIP-chip
has been largely replaced by the sequencing-based ChIP-seq (Barski and Zhao,
2009), and also analysis of gene expression, which is the predominant applica-
tion of microarray, is being replaced by the sequencing-based RNA-seq (Wang
et al., 2009).
We have developed a method to detect DNA copy number variation us-
ing sequencing. This method is conceptually similar to the microarray-based
method, aCGH. Shotgun sequencing reads from test and reference genomes
are mapped to a template genome assembly, and the coverage in the two
genomes can be compared. The use of two genomes is necessary because
the bias in sequencing and mapping due to differential complexities along
the genome. A robust statistical model that describes the complete analysis
procedure and allows the computation of essential confidence values for de-
tection of CNV is also developed. This statistical model also shows that the
new generation sequencing technologies are more suitable for CNV-seq than
traditional sequencing technologies.
The CNV-seq method has the general advantages of sequencing-based
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methods over microarray-based methods. Firstly, sequencing data generated
for CNV-seq can be readily used for other applications, such as SNP genotyping
and whole genome re-sequencing. Secondly, the dynamic range of CNV-seq is
higher than aCGH because there is no inherent detection limit like fluorescence
intensity in microarray approaches. Thirdly, because there is no fixed probes in
CNV-seq, the resolution of CNV boundary detection can in theory reach single
nucleotide level. Fourthly, DNA sequences missing in a reference assembly can
also be detected in CNV-seq but not in the microarray approach due to lack of
specific probes.
7.2 Two-stage Hidden Markov Models
Hidden Markov Model is a natural choice to study hidden-state changes in a
sequence of observations. In CNV-seq experiment, the observed values are the
mapped sequencing reads or read-count ratio along a genome, and we want to
detect the change of the underlying DNA copy number state along the genome.
Therefore, Hidden Markov Model is a good choice to reliably detect CNV and
precisely resolve the boundaries using CNV-seq data.
The most simple way of implementing a HMM for CNV-seq would be to
model the mapped read count-ratios in sliding windows with hidden copy
number ratio states. However, the key problem with this approach is low res-
olution, because the information in CNV boundaries are smoothed by the
sliding windows. To fully utilize sequencing data, we need to consider infor-
mation in each individual read and thus to reach resolution about the average
distance between two adjacently mapped reads. However it is computationally
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impractical to implement a HMM for all mapped reads, therefore we have
developed a two-stage HMM approach to solve the problems.
The first stage uses sliding window based read-count ratios, which enables
fast and reliable CNV detection. The second stage will then focus on the can-
didate CNV boundaries and use information from each individual reads to
achieve the highest possible resolution — the distance between two adjacently
mapped reads. Testing with simulated data shows perfect PPV of CNV detection
and high accuracy of boundary resolving.
With the emergence of the Next-generation and Third-generation sequenc-
ing technologies, it is now feasible to achieve single-nucleotide resolution of
CNV detection.
7.3 Contributions of Our Work
The CNV-seq method was the first robust statistical framework for CNV de-
tection using high-throughput sequencing data. By using a sequencing-based
approach, general limitations of microarrays, such as low dynamic range and
fixed probes, are overcome in CNV-seq. Previous attempts of CNV detection
using simple read depth analysis in sequencing data have problems due to
bias in sequence complexities across a genome and limited quality of genome
assemblies in copy number variable regions. CNV-seq solves these problems by
using two sets of samples and taking ratios. Without a robust statistical model,
important experimental parameters, such as window size or required sequenc-
ing coverage, need to be set arbitrarily, but with the CNV-seq framework, these
7.4 RELATED WORKS 112
parameters can be determined analytically. Significance assessment of CNV
calls can be determined by the model too.
We have also developed a two-stage HMM approach for high resolution
detection of CNV boundaries, based on the CNV-seq statistical model. This is
the first method to utilize information in each individual mapped read and
thus achieve high resolution about the average distance between adjacently
mapped reads.
Both methods are implemented and freely available at http://tiger.dbs.
nus.edu.sg/CNV-seq and http://code.google.com/p/cnv-seghmm.
7.4 Related Works
Chiang et al. (2009) developed a method similar to our CNV-seq. It also uses
Poisson distribution to model number of reads in sliding window, and uses
matched control sample to eliminate other types of bias. Yoon et al. (2009)
developed a control-free method by using GC content to normalize sequencing
and mapping bias. Including our CNV-seq work, those early works lead to fast
development of related methods for detecting CNV using sequencing data.
Zhang and Gerstein (2010) developed a stepwise Bayesian model to detect
copy number variation from array intensity and sequencing read depth. Boeva
et al. (2010) developed a control-free software for calling CNV in sequencing
data using GC-content normalization. Medvedev et al. (2010) developed a
method to detect CNV using mated short reads.
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CNV-seq is a method for detecting DNA copy number variation (CNV) using
high-throughput sequencing, described by Xie and Tammi (2009). This method
provides a statistical framework to estimate parameters (more details can be
found in Xie and Tammi (2009)). The package here is an implementation of
the CNV-seq method. We tested this package in the following configurations:







This package contains two Perl scripts and one R package. To use the CNV-
seq package, you need to install Perl and R first. Then you can download
the CNV-seq package from http://tiger.dbs.nus.edu.sg/CNV-seq. After
downloading the package, open a command line console and run:
$ tar xzf cnv-seq.tar.gz
$ cd cnv-seq
$ ls
There are several Perl scripts (best-hit.*.pl and cnv-seq.pl) and one R
package cnv in this directory. To install the two Perl scripts, simply move or
copy the them to your desired location. To install the R package run:
$ R CMD INSTALL cnv/
Please note that the R package cnv requires package ggplot2 for plotting CNV





The only requirement for CNV-seq is best-hit location files for each mapped






We provide best-hit.*.pl for obtaining the best mapping locations for sev-
eral alignment tools. Currently it only supports BLAT psl file and SOLiD match-
ing pipeline (in corona_lite) output as input. More input formats from various
alignment or mapping programs will be included in the future. You need to
generate your own best-hit file if you are using other alignment tools.
A.3.2 cnv-seq.pl
cnv-seq.pl is used to calculate sliding window size, to count number of
mapped hits in each window, and to call cnv R package to calculate log2 ratios












(default=2, in order to use larger window than minimum)
--genome = (human, chicken, chrom1, autosome, sex, chromX, chromY)
(higher priority than --genome-size)
--genome-size = number
(in bases, overwritten by --genome option)
--global-normalization
(if used, normalization on whole genome,





(default=4; only for annotation of CNV)
--Rexe = path to your R program
(default=R)
--help
The option --test and --ref are mandotory. Either --genome or --genome-size
option must be specified too. All other options have default values as shown
above. The “test” and “ref” options accept the best hit files output from best-hit.*.pl
for the test and reference individuals.
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A.3.3 R package cnv
The cnv-seq.pl will call the R package cnv by default, and a tab-delimited file
containing the log2 ratios and (optionally) CNV annotation will be outputed.
However, in order to achieve the full power of the cnv package, you are strongly
recommended to run the cnv package from R by yourself. The cnv package
contains several functions:
cnv.cal <- function (file, log2.threshold = NA,
chromosomal.normalization = TRUE,
annotate = FALSE, minimum.window = 4)
cnv.print <- function (cnv, file = "")
cnv.summary <- function (cnv)
plot.cnv <- function (data, chromosome = NA,
CNV = NA, ...)
plot.cnv.all <- function (data, chrom.gap = 2e+07,
colour = 5, title = NA, ylim = c(-2,2),
xlabel = "Chromosome")
plot.cnv.chr <- function (data, chromosome = NA,
from = NA, to = NA, title = NA,
ylim = c(-4, 4), glim = c(NA, NA),
xlabel = "Position (bp)")
plot.cnv.cnv <- function (data, CNV, upstream = NA,
downstream = NA, ...)
A.4 Demonstration
We provide some sample data for demonstration. You can download Sam-
ple1.tar.gz from our website. Sample1.tar.gz contains BLAT output for simu-
lated Illumina reads with 1X coverage on human chromosome 1. (Warning:
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samlple1.tar.gz is huge) After download the file, open command line console,
and run:
$ cd DOWNLOAD_DIR
$ tar xzf Sample1.tar.gz
$ PATH-TO/best-hit.BLAT.pl ref.psl > ref.hits
$ PATH-TO/best-hit.BLAT.pl test.psl > test.hits
$ ### NOTE: there are several other versions of
$ ### best-hit.*.pl for different input formats
The above lines will generate two output files: test.hits and ref.hits, which
are the genomic locations of the best BLAT hits. We also provided the two
files (test.hits and ref.hits) on our website as Sample2.tar.gz, which is much
smaller than Sample1.tar.gz. After obtaining the two hits files, you can run
cnv-seq.pl:
$ cnv-seq.pl --test test.hits --ref ref.hits --genome chrom1
--log2 0.6 --p 0.001 --bigger-window 1.5 #default
--annotate --minimum-windows 4 #default
This will give you output like this:
genome size used for calculation is 247249719
test.hits: 1874797 reads
ref.hits: 1878852 reads
The minimum window size for detecting log2>= 0.6 should be 17676
The minimum window size for detecting log2<=-0.6 should be 17692
window size to use is 17692.0064154661 x 1.5 = 26538
window size to be used: 26538
read 1874797 test reads, out of 1874797 lines
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read 1878852 ref reads, out of 1878852 lines
write read-counts into file: test.hits-vs-ref.hits.log2-...
R package cnv output: test.hits-vs-ref.hits.log2-0.6.pva...
...
[1] "chromosome: 1"
[1] "cnv_id: 1 of 50"
[1] "cnv_id: 2 of 50"
[1] "cnv_id: 3 of 50"
[1] "cnv_id: 4 of 50"
...
The sliding window size used is 26.5Kb.
This will give a tab delimited file test.hits-vs-ref.hits.log2-0.6.pvalue-0.001.minw-
4.cnv. This file contains all information about CNV prediction from the analysis.
In order to plot the log2 CNV graph:
$ R
# in R command prompt
> library(cnv)





> plot.cnv(data, CNV=4, upstream=4e+6, downstream=4e+6)
> ggsave("sample.pdf")





CNV-segHMM is an implementation of the two-stage Hidden Markov Model
approach for CNV-seq data analysis. The first stage HMM utilizes sliding win-
dow based read count-ratios to estimate the location of candidate CNV re-
gions. The second stage will examine each candidate CNV boundaries from
the first stages separately. Each individual mapped reads around the candidate
boundaries will be considered, thus the resolution could theoretically reach




CNV-segHMM should work on any modern Linux or UNIX operating systems,




Several R packages are required, which can be installed from within R by
typing:
install.packages(c(RHmm, ggplot2))
To install CNV-segHMM, you simply download the package from http://code.
google.com/p/cnv-seghmm and put the two files (segHMM.pl and lib.segHMM.r)
in the same directory.
B.3 Input Format
You need prepare two input files for CNV-segHMM — the best hit location
files for one test and one reference sample. (If you only have one sample, you
can try to simulate a set of sequencing data using the same sequencing and
mapping method as your real data). The format for the best hit location file is
very simple:
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1. Each line represent the location of one mapped read
2. Each line must contain a chromosome id followed by the mapped posi-
tion, separated by a TAB. No extra spaces are allowed
3. The mapped locations must be sorted, from beginning of a chromosome
to the end










There are two sample data files available at the project download page: KB1.chr22.hits.bz2
and ABT.chr22.hits.bz2. The are the best hit map locations on chromosome
22 from two recently sequenced Bushmen genome(Schuster et al., 2010).
B.4 Usage




### for stage 1 ###
--test = test.hits.file
(sorted, only one chromosome)
--ref = ref.hits.file









--cw (default; simple consecutive window annotation)
--no-cw




### for stage 2 ###
--refine = stage.1.log
(all other options will be overwritten)
### others ###




Two of the parameters are required: --test and --ref, which are the best hit




Only one parameter is required for the second stage: --refine, which is the
path to the log file (with file extension of *.log) created by the first stage.
B.5 Tutorial
(Download the sample data from the project home page)
B.5.1 Stage 1
$ ~/cnv/segHMM/segHMM.pl --test KB1.chr22.hits --ref ABT.chr22.hits
... minimum reads for log2>= 0.6 should be 715(test) and 188(ref)
... minimum reads for log2<=-0.6 should be 448(test) and 118(ref)
... each window should contain, after X 1.5:
minimum 1072 test reads or minimum 282 ref reads
check out the log for a list of output:
KB1.chr22.hits-vs-ABT.c...g2-0.6.pvalue-1e-05.minw-3.cw.hmm.log
Loading required package: RHmm
Loading required package: MASS
Loading required package: nlme
Loading required package: plyr
Simple consecutive windows ...
found 35 CNV segments
HMM-ing ...
found 59 CNV segments







Do not rename them yet, because they are required by the second stage. The
*.count file contains the raw read counts. The *.cnv.raw file contains all
information produced in the first stage, some of which will be used when
plotting the predicted CNVs later. The *.cw file contains CNV regions detected
based on consecutive windows. The file *.hmm.rough contains the candidate
CNV regions detected by the first stage HMM. The regions in this file will be
refined in the second stage HMM. The file *.log contains a rough description
of the files produced by CNV-segHMM.
B.5.2 Stage 2
To refine the rough CNV candidate detected by the first stage:
$ PATH-TO/segHMM.pl --refine KB1.chr22.hits-vs-...minw-3.cw.hmm.log
44 1 21300145 21324779 24635 2
33 1 21361985 21420338 58354 1
40 1 21979496 21991802 12307 1.58496250072116
15 1 21998053 22019959 21907 0.584962500721156
Warning message:
In hmm.bound("...hmm.refined.cand/16.cand", :
cannot determine bound reliably, check the *.unreliable file
Most likely you will see Warning messages like the above. That is because the
second stage cannot reliably detect the boundaries for some candidate CNV
regions. Those regions are not refined by the second stage, and stored with the




Check the candidate regions in the *.unreliable file together with raw data
carefully. Some of the regions are in low complexity regions and thus should
not be classified as CNV, but some of them are part of real CNV broken into
pieces by the first stage. At this moment, CNV-segHMM will not try to make
over-confident predictions.




Plotting functions are provided by the R functions. Enter the following com-
mands in R:
# load the R functions
source('~/cnv/segHMM/lib.segHMM.r')
# load the refined CNV list
cnv <- read.delim('KB1.chr22.hits-vs-ABT.chr22.hits.log2-
0.6.pvalue-1e-05.minw-3.cw.hmm.hmm.refined')
# load window-level raw data
raw <- read.delim('KB1.chr22.hits-vs-ABT.chr22.hits.log2-
0.6.pvalue-1e-05.minw-3.cw.hmm.cnv.raw')
# specify directory for read-level raw data
cand <- 'KB1.chr22.hits-vs-ABT.chr22.hits.log2-
0.6.pvalue-1e-05.minw-3.cw.hmm.hmm.refined.cand'
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CNV Between Venter and Watson
The CNV regions detected between Venter and Watson. Information on their
location (chromosome, start, and end position), log2ratios, and associated p-
values are shown here.
C.1 CNVs detected by simple consecutive windows
chrom start end log2 p-value
=============================================
1 13282426 13426920 1.300 8.38e-216
1 17639506 17728425 0.608 1.86e-43
160
C.1 CNVS DETECTED BY SIMPLE CONSECUTIVE WINDOWS 161
1 103958596 104091975 0.835 7.80e-118
1 142405381 142572105 0.855 5.62e-103
1 142905556 143016705 0.884 6.05e-88
1 144772876 144895140 0.913 4.36e-116
1 146373436 146506815 -1.501 1.26e-201
1 194990446 195079365 -0.969 3.68e-73
10 17828461 18017415 2.436 0.00e+00
10 45660421 45893835 0.966 2.47e-103
10 46004986 46316205 1.157 0.00e+00
11 48594781 48828195 1.484 2.81e-213
11 50406526 50962275 1.125 0.00e+00
11 55119286 55208205 0.842 2.06e-80
12 34312006 34678800 1.330 3.53e-268
12 36268246 36535005 1.820 0.00e+00
12 120564406 120675555 0.739 3.07e-78
15 18484246 18639855 0.981 1.19e-184
15 18906616 19039995 1.117 1.10e-199
15 20073691 20284875 0.824 6.35e-96
15 80383681 80617095 1.244 0.00e+00
15 100268416 100357335 -0.689 1.84e-42
16 24241816 24375195 0.626 4.30e-68
16 29354716 29465865 1.001 2.72e-137
16 88731046 88842195 1.188 1.90e-185
17 41736826 41914665 1.451 0.00e+00
17 41558986 41647905 -0.862 5.21e-61
19 32466916 32689215 1.447 0.00e+00
2 110716516 110805435 1.249 6.93e-162
2 242607106 242762715 0.780 1.44e-120
22 18951076 19039995 -1.012 3.47e-78
22 19906966 20040345 -0.892 9.51e-96
4 68913001 69035265 1.197 1.13e-150
4 70168996 70280145 0.847 5.07e-101
4 144261586 144372735 1.504 1.62e-271
5 46138366 46405125 1.394 1.16e-193
5 68990806 69079725 1.338 3.17e-181
C.1 CNVS DETECTED BY SIMPLE CONSECUTIVE WINDOWS 162
5 69168646 69257565 1.158 1.75e-142
5 69302026 69457635 0.999 7.00e-164
5 69479866 69568785 0.940 1.70e-98
5 180274186 180363105 0.937 7.77e-98
5 49561786 49650705 -1.093 1.28e-87
5 70569136 70702515 -0.954 2.47e-106
6 170826436 170915355 1.802 1.76e-281
6 29954926 30043845 -1.307 9.53e-113
7 56464201 61321455 1.182 0.00e+00
7 61577101 62010585 0.949 8.67e-174
7 72169696 72325305 1.003 3.30e-192
7 101913436 102002355 1.204 3.44e-152
8 11116 100035 1.209 2.56e-153
8 7058026 7146945 1.363 7.26e-187
8 7213636 7480395 1.519 0.00e+00
8 7591546 7836075 1.527 0.00e+00
8 7880536 7969455 1.872 6.60e-296
8 8013916 8147295 0.804 1.47e-109
8 11937511 12182040 1.982 0.00e+00
8 12370996 12526605 1.019 7.32e-198
8 43504111 43959825 0.990 3.56e-161
8 47049796 47527740 0.884 2.49e-109
9 39191491 39402675 1.012 9.27e-168
9 39436021 39613860 0.978 1.18e-105
9 39913966 40314105 0.954 0.00e+00
9 40892086 41136615 1.312 0.00e+00
9 41247766 41347800 1.094 3.55e-129
9 43215121 43337385 1.049 8.87e-120
9 45382546 45582615 1.509 0.00e+00
9 46738576 46871955 0.805 5.22e-110
9 65567386 65656305 1.067 1.23e-123
9 66412126 66523275 0.694 1.97e-69
9 68079376 68168295 0.692 1.62e-55
9 68968576 69057495 1.083 9.42e-127
9 123320926 123432075 1.102 6.66e-163
C.2 CNVS DETECTED BY HIDDEN MARKOV MODEL APPROACH 163
9 44404426 44537805 -0.801 1.34e-80
C.2 CNVs detected by Hidden Markov Model Approach
chrom start end log2
=============================================
1 366796 544635 0.680
1 13282426 13426920 1.284
1 17639506 17750655 0.655
1 31310956 31466565 0.695
1 47227636 47338785 -0.742
1 54808066 54919215 0.607
1 75126286 75259665 -0.625
1 103958596 104091975 0.929
1 142405381 142572105 1.102
1 142905556 143016705 0.962
1 144528346 144895140 0.890
1 146373436 146506815 -1.345
1 194990446 195190515 -0.726
2 96422626 96533775 0.296
2 110694286 110949930 -0.103
2 242607106 242762715 0.014
3 9547786 9658935 -0.160
3 12659986 12793365 -0.083
4 68913001 69035265 0.164
4 70146766 70280145 0.164
4 144261586 144372735 0.067
5 46138366 46405125 0.024
5 44837911 49650705 0.024
5 68968576 69568785 0.154
5 69946696 70057845 0.154
5 70569136 70769205 0.154
5 180274186 180363105 -0.172
6 29954926 30043845 -0.027
C.2 CNVS DETECTED BY HIDDEN MARKOV MODEL APPROACH 164
6 79016536 79105455 0.097
6 170826436 170915355 0.002
7 56953261 57119985 0.159
7 56464201 61321455 0.159
7 61454836 62010585 0.159
7 72169696 72325305 0.094
7 101913436 102113505 0.135
8 11116 100035 0.032
8 7058026 8147295 0.051
8 11937511 12526605 -0.080
8 42203656 47716695 -0.348
9 39180376 39613860 0.187
9 39891736 40025115 0.002
9 40036231 40314105 0.002
9 40892086 41347800 0.002
9 41347801 41647905 0.226
9 43181776 43337385 -0.182
9 45382546 45560385 0.008
9 46738576 46871955 0.008
9 65567386 65656305 0.253
9 68001571 68257215 -0.129
9 68968576 69057495 0.069
9 69235336 69524325 0.069
9 123320926 123432075 0.049
10 17884036 18017415 -0.040
10 45660421 46316205 0.054
10 47183176 47650005 0.054
10 80928316 81217305 -0.061
11 48594781 48828195 0.053
11 50406526 50651055 0.053
11 55119286 55208205 -0.053
12 34312006 34678800 0.154
12 120564406 120675555 0.062
12 130301146 130390065 0.018
13 19328986 19417905 -0.048
C.2 CNVS DETECTED BY HIDDEN MARKOV MODEL APPROACH 165
13 113584186 113673105 0.159
14 105848146 105981525 -0.046
15 18484246 18639855 -0.046
15 18906616 19017765 -0.046
15 20907316 20996235 -0.168
15 80383681 80617095 -0.112
15 100268416 100357335 -0.057
16 8969806 9080955 -0.774
16 24219586 24441885 0.040
16 29288026 29465865 0.034
16 30210571 45004635 -0.002
16 88731046 88842195 -0.088
17 33400576 33533955 -0.067
17 41514526 41759055 0.041
17 41759056 41914665 -0.168
19 20240416 32778135 -0.027
22 18951076 19039995 0.239
22 19840276 20040345 -0.138
1 194990446 195079365 -1.000
1 17639506 17750655 1.000
1 31310956 31466565 1.000
1 104003056 104091975 1.000
10 45660421 45949410 1.000
10 46004986 46249515 1.000
10 47183176 47416590 1.000
10 81128386 81217305 1.000
11 50406526 50651055 1.000
11 55119286 55208205 1.000
11 48594781 48828195 1.585
12 130301146 130390065 -1.000
12 7702696 7813845 1.000
12 31888936 32000085 1.000
12 120564406 120675555 1.000
13 19328986 19417905 1.000
15 100268416 100357335 -1.000
C.2 CNVS DETECTED BY HIDDEN MARKOV MODEL APPROACH 166
15 18550936 18639855 1.000
15 18884386 18973305 1.000
15 20073691 20307105 1.000
15 41625676 41714595 1.000
15 80383681 80528175 1.000
16 32600296 32689215 -1.000
16 33000436 33089355 -1.000
16 33445036 33578415 -1.000
16 33622876 33711795 -1.000
16 8992036 9080955 1.000
16 24219586 24375195 1.000
16 29354716 29465865 1.000
16 88731046 88842195 1.000
17 41514526 41736825 -1.000
17 18306406 18395325 1.000
17 41825746 41914665 1.585
19 32511376 32600295 1.000
19 32589181 32778135 1.000
19 44204356 44293275 1.000
2 96422626 96511545 1.000
2 242607106 242762715 1.000
22 18951076 19039995 -1.000
22 19840276 19995885 -1.000
3 9547786 9658935 1.000
3 12682216 12793365 1.000
4 70168996 70280145 1.000
5 49561786 49650705 -1.000
5 69968926 70057845 -1.000
5 70569136 70702515 -1.000
5 69168646 69257565 1.000
5 69379831 69568785 1.000
5 180274186 180363105 1.000
6 79016536 79105455 1.000
7 56953261 57119985 1.000
7 56464201 61099155 1.000
C.3 CNVS DETECTED BY CIRCULAR BINARY SEGMENTATION 167
7 61454836 62010585 1.000
7 69924466 70013385 1.000
7 72169696 72325305 1.000
7 73370116 73481265 1.000
7 74259316 74470500 1.000
8 7213636 7324785 1.000
8 8013916 8147295 1.000
8 12304306 12526605 1.000
8 43504111 43937595 1.000
8 47049796 47583315 1.000
9 41425606 41625675 -1.000
9 44404426 44537805 -1.000
9 39191491 39369330 1.000
9 39436021 39613860 1.000
9 39913966 40158495 1.000
9 40202956 40314105 1.000
9 42759406 42870555 1.000
9 43215121 43337385 1.000
9 44837911 45004635 1.000
9 46105021 46227285 1.000
9 46738576 46871955 1.000
9 65567386 65656305 1.000
9 66356551 66523275 1.000
9 68079376 68168295 1.000
C.3 CNVs detected by Circular Binary Segmentation
chrom start end log2
=============================================
1 366796 544635 0.680
1 13282426 13426920 1.284
1 17639506 17750655 0.655
1 31310956 31466565 0.695
1 47227636 47338785 -0.742
C.3 CNVS DETECTED BY CIRCULAR BINARY SEGMENTATION 168
1 54808066 54919215 0.607
1 75126286 75259665 -0.625
1 103958596 104091975 0.929
1 142405381 142572105 1.102
1 142905556 143016705 0.962
1 144528346 144895140 0.890
1 146373436 146506815 -1.345
1 194990446 195190515 -0.726
2 96422626 96533775 0.296
2 110694286 110949930 -0.103
2 242607106 242762715 0.014
3 9547786 9658935 -0.160
3 12659986 12793365 -0.083
4 68913001 69035265 0.164
4 70146766 70280145 0.164
4 144261586 144372735 0.067
5 46138366 46405125 0.024
5 44837911 49650705 0.024
5 68968576 69568785 0.154
5 69946696 70057845 0.154
5 70569136 70769205 0.154
5 180274186 180363105 -0.172
6 29954926 30043845 -0.027
6 79016536 79105455 0.097
6 170826436 170915355 0.002
7 56953261 57119985 0.159
7 56464201 61321455 0.159
7 61454836 62010585 0.159
7 72169696 72325305 0.094
7 101913436 102113505 0.135
8 11116 100035 0.032
8 7058026 8147295 0.051
8 11937511 12526605 -0.080
8 42203656 47716695 -0.348
9 39180376 39613860 0.187
C.3 CNVS DETECTED BY CIRCULAR BINARY SEGMENTATION 169
9 39891736 40025115 0.002
9 40036231 40314105 0.002
9 40892086 41347800 0.002
9 41347801 41647905 0.226
9 43181776 43337385 -0.182
9 45382546 45560385 0.008
9 46738576 46871955 0.008
9 65567386 65656305 0.253
9 68001571 68257215 -0.129
9 68968576 69057495 0.069
9 69235336 69524325 0.069
9 123320926 123432075 0.049
10 17884036 18017415 -0.040
10 45660421 46316205 0.054
10 47183176 47650005 0.054
10 80928316 81217305 -0.061
11 48594781 48828195 0.053
11 50406526 50651055 0.053
11 55119286 55208205 -0.053
12 34312006 34678800 0.154
12 120564406 120675555 0.062
12 130301146 130390065 0.018
13 19328986 19417905 -0.048
13 113584186 113673105 0.159
14 105848146 105981525 -0.046
15 18484246 18639855 -0.046
15 18906616 19017765 -0.046
15 20907316 20996235 -0.168
15 80383681 80617095 -0.112
15 100268416 100357335 -0.057
16 8969806 9080955 -0.774
16 24219586 24441885 0.040
16 29288026 29465865 0.034
16 30210571 45004635 -0.002
16 88731046 88842195 -0.088
C.4 GENES IN THE CNV REGIONS DETECTED BY SIMPLE CONSECUTIVE
WINDOWS 170
17 33400576 33533955 -0.067
17 41514526 41759055 0.041
17 41759056 41914665 -0.168
19 20240416 32778135 -0.027
22 18951076 19039995 0.239
22 19840276 20040345 -0.138
C.4 Genes in the CNV regions detected by simple
consecutive windows
Ensembl ID Name Chrom Start End
==============================================================
ENSG00000220732 RP11-219C24.6 1 13284138 13287069
ENSG00000204501 PRAMEF9 1 13293763 13300778
ENSG00000204488 PRAMEF16 1 13367853 13370847
ENSG00000204486 PRAMEF21 1 13388653 13399530
ENSG00000196318 AMY2A 1 103960956 103969925
ENSG00000051415 AMY1A 1 103999825 104102834
ENSG00000219295 AMYP1 1 104057868 104064016
ENSG00000206694 U1 1 142478882 142479043
ENSG00000215862 BX284650.8 1 142491439 142501807
ENSG00000218201 BX284650.4 1 142511227 142513042
ENSG00000162825 BX511041.14 1 142858167 142932413
ENSG00000198658 FAM108A3 1 144787932 144791588
ENSG00000202456 5S_rRNA 1 144835515 144835622
ENSG00000218680 RP11-91G11.1 1 146373839 146375680
ENSG00000212456 U1 1 146460770 146460937
ENSG00000220427 RP6-74O6.1 1 146466837 146467118
ENSG00000116785 CFHR3 1 195010553 195031160
ENSG00000080910 CFHR1 1 195055484 195067940
ENSG00000204098 AC093642.5 2 242573981 242656206
ENSG00000220804 AC134873.2 2 242679518 242729712
ENSG00000213761 AC074378.4 4 68924567 68924964
C.4 GENES IN THE CNV REGIONS DETECTED BY SIMPLE CONSECUTIVE
WINDOWS 171
ENSG00000087128 TMPRSS11E 4 68995762 69045917
ENSG00000135226 UGT2B28 4 70180806 70195356
ENSG00000170185 USP38 4 144325548 144362087
ENSG00000212653 AC139277.2 5 69252309 69310192
ENSG00000205572 SERF1B 5 69356852 69374696
ENSG00000205571 SMN2 5 69381106 69409175
ENSG00000113303 BTNL8 5 180258735 180310510
ENSG00000204637 AC091874.4 5 180341879 180342217
ENSG00000168903 BTNL3 5 180348507 180366317
ENSG00000196306 AL645929.4 6 29963368 29966825
ENSG00000220463 HLA-16 6 29972410 29973542
ENSG00000217224 BAT1P1 6 29982299 29982665
ENSG00000219322 HLA-K 6 30002215 30004988
ENSG00000217998 HLA-21 6 30009857 30010042
ENSG00000206503 HLA-A 6 30017016 30021640
ENSG00000219848 HLA-80 6 30032352 30034326
ENSG00000219814 XX-C2158C6.2 6 170896629 170896992
ENSG00000188639 AC118758.3 7 56839246 56856131
ENSG00000203451 AC118758.3 7 56839912 56840122
ENSG00000189166 TNRC18C 7 57075980 57080801
ENSG00000210856 AC099654.5 7 57238624 57238687
ENSG00000210860 AC099654.5 7 57240306 57240373
ENSG00000210866 AC099654.5 7 57240725 57240791
ENSG00000210874 AC099654.5 7 57242425 57242492
ENSG00000210882 AC099654.5 7 57242494 57242552
ENSG00000210891 AC099654.5 7 57242553 57242623
ENSG00000210899 AC099654.5 7 57246026 57246092
ENSG00000210921 AC099654.5 7 57257996 57258062
ENSG00000210923 AC099654.5 7 57259099 57259166
ENSG00000210970 AC099654.5 7 57261159 57261226
ENSG00000209029 AC099654.5 7 57261879 57261948
ENSG00000210982 AC099654.5 7 57263580 57263645
ENSG00000210985 AC099654.5 7 57263987 57264053
ENSG00000210994 AC099654.5 7 57265724 57265791
ENSG00000210996 AC099654.5 7 57265793 57265851
C.4 GENES IN THE CNV REGIONS DETECTED BY SIMPLE CONSECUTIVE
WINDOWS 172
ENSG00000210999 AC099654.5 7 57265852 57265922
ENSG00000211008 AC099654.5 7 57269431 57269497
ENSG00000182111 ZNF716 7 57513831 57534142
ENSG00000182487 NCF1B 7 72272617 72287914
ENSG00000205238 AC004084.7 7 101983352 101989855
ENSG00000215376 FAM90A3 8 7109458 7112468
ENSG00000215373 FAM90A5 8 7132324 7135886
ENSG00000196815 FAM90A20 8 7139946 7142956
ENSG00000215371 DEFB108P1 8 7218046 7222432
ENSG00000209992 AC130360.4 8 7237354 7237443
ENSG00000216194 AC130360.4 8 7302888 7302982
ENSG00000186599 DEFB105B 8 7332649 7334483
ENSG00000198129 DEFB107B 8 7340778 7354243
ENSG00000216302 AC134684.5 8 7391815 7392249
ENSG00000217180 AC134684.5 8 7399470 7399904
ENSG00000220775 AC134684.5 8 7407120 7407554
ENSG00000217851 AC134684.5 8 7414766 7415200
ENSG00000220619 AC134684.5 8 7422415 7422849
ENSG00000217757 AC134684.5 8 7430060 7430494
ENSG00000217812 AC134684.8 8 7436938 7437848
ENSG00000189393 FAM90A13 8 7610375 7613385
ENSG00000186579 DEFB106A 8 7720104 7723985
ENSG00000176782 DEFB104A 8 7731403 7736178
ENSG00000178287 SPAG11A 8 7742812 7758728
ENSG00000176797 DEFB103B 8 7776136 7777515
ENSG00000171711 DEFB4 8 7789609 7791647
ENSG00000215356 AC130365.5 8 7821269 7847345
ENSG00000164845 AC068020.7 8 8123537 8132176
ENSG00000173295 AC068020.7 8 8135301 8139794
ENSG00000215343 ZNF705D 8 12003090 12008076
ENSG00000205873 AC068587.16 8 12338997 12468794
ENSG00000221714 AC130352.6 8 12428619 12428721
ENSG00000221231 AC068587.16 8 12479885 12480032
ENSG00000221295 AC134698.10 8 43534968 43535073
ENSG00000218397 RP11-347J14.3 9 39320806 39321113
C.4 GENES IN THE CNV REGIONS DETECTED BY SIMPLE CONSECUTIVE
WINDOWS 173
ENSG00000204849 FAM75A1 9 39345699 39351959
ENSG00000204847 FAM74A1 9 39361240 39361537
ENSG00000218183 CTD-2173L22.3 9 39475376 39475865
ENSG00000216379 RP11-381G8.1 9 39475380 39475866
ENSG00000185020 AL592525.10 9 40297346 40329528
ENSG00000217475 RP11-242D12.2 9 41018804 41020127
ENSG00000220140 CTD-2340F8.2 9 41018807 41020090
ENSG00000216756 CTD-2340F8.3 9 41021936 41022439
ENSG00000197805 BX649597.2 9 43253710 43254498
ENSG00000220887 RP11-475I24.5 9 44411921 44413406
ENSG00000217415 AL162415.3 9 44498934 44500281
ENSG00000217259 AL162415.4 9 44502089 44502584
ENSG00000187060 AL354718.10 9 45331933 45453557
ENSG00000210959 AL953889.9 9 45551983 45552266
ENSG00000220325 RP11-211N8.4 9 46752479 46753964
ENSG00000219558 BX664724.2 9 46838033 46839853
ENSG00000216221 BX664724.4 9 46841154 46841655
ENSG00000220533 RP11-391M20.1 9 68116449 68135817
ENSG00000217252 RP11-460N11.4 9 69020356 69021057
ENSG00000218711 RP11-460N11.5 9 69022170 69022683
ENSG00000136848 DAB2IP 9 123368983 123587630
ENSG00000148483 FAM23A 10 17834257 17882873
ENSG00000183748 MRC1L1 10 17891368 17993184
ENSG00000207937 hsa-mir-511-2 10 17927113 17927199
ENSG00000222318 U4 10 17984823 17985005
ENSG00000223222 5S_rRNA 10 45671761 45671876
ENSG00000197374 AC012044.15 10 45682692 45683000
ENSG00000222606 5S_rRNA 10 46162034 46162149
ENSG00000216660 GLUDP7 10 46192800 46198900
ENSG00000215097 AL603982.7 10 46193453 46195217
ENSG00000181927 OR4P4 11 55162410 55163348
ENSG00000174982 OR4S2 11 55174956 55175891
ENSG00000181903 OR4C6 11 55186202 55190738
ENSG00000188439 OR4P1P 11 55207563 55208324
ENSG00000188735 TMEM120B 12 120635163 120698088
C.4 GENES IN THE CNV REGIONS DETECTED BY SIMPLE CONSECUTIVE
WINDOWS 174
ENSG00000203613 AC087386.7 15 18609410 18610046
ENSG00000181984 AC131280.9 15 19027714 19041033
ENSG00000222469 SRP_euk_arch 15 19036232 19036510
ENSG00000209387 AC131280.9 15 19036299 19036457
ENSG00000221354 AC131280.9 15 19037384 19037466
ENSG00000197978 AC135995.7 15 80509240 80518615
ENSG00000188792 AC135995.7 15 80541707 80543029
ENSG00000188384 AC135995.7 15 80543906 80556454
ENSG00000185596 WASH1 15 100319118 100334282
ENSG00000006116 CACNG3 16 24174382 24281238
ENSG00000214734 AC133555.3 16 29361070 29377846
ENSG00000181625 GIYD1 16 29373376 29377041
ENSG00000213648 SULT1A4 16 29373902 29383801
ENSG00000222359 U6 16 88738501 88738604
ENSG00000210972 AC133919.3 16 88738502 88738604
ENSG00000214401 AC005829.1 17 41626716 41627083
ENSG00000176681 LRRC37A 17 41726926 41770918
ENSG00000222905 SRP_euk_arch 17 41752812 41753090
ENSG00000188280 AC007731.16 22 19022622 19046647
ENSG00000220408 KB-1183D5.9 22 19952450 19953192
ENSG00000216420 KB-1183D5.10 22 19967170 19968450
ENSG00000198567 AP000552.1 22 19975342 19978982
ENSG00000216225 KB-1183D5.15 22 20025884 20029531
D
Background on Hidden Markov
Model
Hidden Markov Model (HMM) is a statistical model first applied to speech
recognition in 1970s (Huang et al., 1990). The major task of HMM is to estimate
the sequence of hidden states in a system based on a sequence of observable
values. There are four types of parameters in a HMM — the hidden states,
the emission probabilities, the transition probabilities, and the initial state
distribution. We will use the classical dishonest casino example to explain
those parameters and how a HMM works.
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176
Imagine a casino where the game of coin tossing is being played. This
casino is occasionally dishonest, and both fair and loaded coins could be used.
The fair coin has equal probability of tossing a head or tail, while the loaded
coin has higher probability of tossing a head than a tail. To be safe, the casino
only changes the coin with a low frequency during the game. We do not know
when a fair or loaded coin is used, but we want to model that using HMM by
observing the sequence of heads or tails.
Now we can explain the four types of parameters using the game. First,
there are two hidden states in the system — fair and loaded coins. The sequence
of the hidden states is of our interest, which is the sequence of fair or loaded
coin being used during a game. However, we can only observe the sequence
of heads and tails, not the hidden stages. A fair or loaded coin has its own
probability of tossing a head or tail, and those probabilities are the emission
probabilities. We also need to know the probabilities of changing between
a fair and a loaded coin during the game, and those probabilities are the
transition probabilities. We can calculate the probability of current state, given
the transition probabilities and the previous state. However, this approach
cannot be applied for the first state, because there is no previous state to the
initial state. Therefore, we need to know the initial state distribution.
If we know the four groups of parameters, we can build a HMM for the coin
tossing game. Given a sequence of observed heads and tails, we can calculate
the most probable sequence of hidden states, using an algorithm called the
Viterbi algorithm (Viterbi, 1967). Even if we do not know the exact values of
the emission and transition probabilities, we can estimate them using only
observed sequences with the Baum–Welch algorithm (Baum et al., 1970).
E
A Subset of CNV Regions Detected
Between KB1 and ABT Genomes
(Due to space constraint, only a subset of detected regions are shown here)
chromosome start end size log2 ratio
========================================================
chr10 22452701 22459090 6390 2.170
chr10 37496655 37518739 22085 8.736
chr10 42015039 42051155 36117 2.459
chr10 45992613 46366804 374192 8.736
chr10 47045146 47056536 11391 2.459
chr10 75097562 75115124 17563 2.000
177
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chr10 80926698 81602770 676073 8.736
chr10 88968715 89139281 170567 2.459
chr10 109863653 109869791 6139 2.459
chr10 111562038 111568205 6168 8.736
chr10 127623690 127629744 6055 2.459
chr10 135086483 135099730 13248 2.459
chr10 135139883 135171090 31208 2.459
chr10 135350807 135372049 21243 2.170
chr11 3224830 3234222 9393 9.404
chr11 3235463 3316200 80738 2.459
chr11 4229003 4263376 34374 2.459
chr11 4268606 4275065 6460 9.404
chr11 7712531 7718593 6063 2.459
chr11 18898426 18922370 23945 2.459
chr11 26943347 26949631 6285 2.459
chr11 48822561 48834284 11724 2.459
chr11 49753229 49775646 22418 2.459
chr11 50031581 50050525 18945 9.404
chr11 50259417 50280060 20644 9.404
chr11 51423807 54550467 3126661 2.459
chr11 60729602 60770272 40671 9.404
chr11 62958932 62965269 6338 2.459
chr11 89115736 89184619 68884 2.459
chr11 89296823 89381884 85062 9.404
chr11 89772638 89778909 6272 2.459
chr11 90339024 90350427 11404 2.459
chr11 92793223 92801023 7801 9.404
chr11 93409708 93415742 6035 2.459
chr11 95778308 95784427 6120 2.459
chr11 101071015 101080459 9445 2.459
chr11 106739390 106754406 15017 9.404
chr12 9327479 9354118 26640 2.459
chr12 9458726 9491637 32912 2.000
chr12 13435786 13444304 8519 2.459
chr12 37477956 37488195 10240 2.322
179
chr12 40346424 40358606 12183 2.459
chr12 50239751 50248655 8905 8.670
chr12 53761621 53782246 20626 2.459
chr12 57007548 57016812 9265 8.670
chr12 62875557 62881680 6124 2.459
chr12 64026010 64034475 8466 2.000
chr12 91595749 91604309 8561 2.000
chr12 96640046 96647652 7607 2.459
chr12 100064224 100072948 8725 2.459
chr12 125349395 125355548 6154 8.670
chr12 130347504 130358917 11414 2.459
chr12 131321723 131329387 7665 2.459
chr13 18239948 18255167 15220 9.385
chr13 29113745 29119872 6128 9.385
chr13 40207468 40213527 6060 2.459
chr13 45117330 45123349 6020 2.459
chr13 45136193 45142351 6159 2.459
chr13 49652148 49658328 6181 2.459
chr13 51700905 51779874 78970 2.459
chr13 51976751 52059805 83055 2.000
chr13 56611456 56645778 34323 2.459
chr13 63221354 63241451 20098 9.385
chr13 92939157 92946231 7075 2.000
chr13 97117566 97123736 6171 2.459
chr14 18130045 18141576 11532 2.459
chr14 18195764 18334115 138352 2.459
chr14 18338264 18501585 163322 2.459
chr14 18515857 18559110 43254 2.459
chr14 18573642 18840786 267145 8.683
chr14 18897115 19151625 254511 8.683
chr14 19167885 19262347 94463 2.459
chr14 21096068 21106087 10020 -8.683
chr14 29902444 29908640 6197 2.459
chr14 34079790 34086780 6991 8.683
chr14 34094308 34101157 6850 8.683
180
chr14 42793862 42806975 13114 2.000
chr14 44243952 44249991 6040 2.459
chr14 45015940 45022129 6190 2.459
chr14 55978249 55984377 6129 2.459
chr14 70011649 70019491 7843 2.170
chr14 85631986 85646914 14929 2.459
chr14 92949175 92955210 6036 2.170
chr14 104767027 104778267 11241 8.683
chr14 105868476 105890562 22087 8.683
chr15 18458612 18502165 43554 2.000
chr15 18515270 18526243 10974 2.459
chr15 18531659 18631973 100315 8.685
chr15 18634544 18650829 16286 2.322
chr15 18923204 18977343 54140 8.685
chr15 18978299 19080794 102496 2.459
chr15 19481141 19529730 48590 2.459
chr15 19543492 19571518 28027 8.685
chr15 19573555 19766630 193076 2.459
chr15 20803573 20851364 47792 2.459
chr15 20853578 21001112 147535 8.685
chr15 26240573 26494946 254374 8.685
chr15 30233167 30685975 452809 8.685
chr15 32461094 32491891 30798 8.685
chr15 32606923 32647058 40136 2.459
chr15 41639910 41675960 36051 8.685
chr15 41684902 41698777 13876 2.459
chr15 41729478 41735507 6030 2.170
chr15 41739340 41775674 36335 8.685
chr15 41789020 41798220 9201 8.685
chr15 42902709 42910234 7526 2.000
chr15 62405673 62411832 6160 2.459
chr15 70710936 70749241 38306 8.685
chr15 72147978 72178440 30463 8.685
chr15 73333982 73374591 40610 8.685
chr15 82625257 82706065 80809 8.685
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chr15 82749395 82861084 111690 8.685
chr15 83777980 83784114 6135 2.459
chr15 85854217 85860240 6024 8.685
chr15 100110339 100122232 11894 8.685
chr15 100217789 100239345 21557 2.000
chr15 100250409 100337934 87526 8.685
chr16 1217565 1227833 10269 2.459
chr16 2542579 2574356 31778 10.421
chr16 11926292 11942887 16596 2.459
chr16 14689239 14770476 81238 10.421
chr16 15102782 15384195 281414 2.459
chr16 16605400 16623469 18070 2.459
chr16 16640649 16652632 11984 2.459
chr16 18076558 18291807 215250 2.459
chr16 18294465 18443908 149444 10.421
chr16 18448010 18494938 46929 2.459
chr16 18518689 18683709 165021 2.459
chr16 20361664 20369443 7780 10.421
chr16 20408982 20420017 11036 10.421
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Abstract
Background: DNA copy number variation (CNV) has been recognized as an important source of
genetic variation. Array comparative genomic hybridization (aCGH) is commonly used for CNV
detection, but the microarray platform has a number of inherent limitations.
Results: Here, we describe a method to detect copy number variation using shotgun sequencing,
CNV-seq. The method is based on a robust statistical model that describes the complete analysis
procedure and allows the computation of essential confidence values for detection of CNV. Our
results show that the number of reads, not the length of the reads is the key factor determining
the resolution of detection. This favors the next-generation sequencing methods that rapidly
produce large amount of short reads.
Conclusion: Simulation of various sequencing methods with coverage between 0.1× to 8× show
overall specificity between 91.7 – 99.9%, and sensitivity between 72.2 – 96.5%. We also show the
results for assessment of CNV between two individual human genomes.
Background
DNA copy number variation (CNV) has long been known
as a source of genetic variation, but its importance has
only been recognized recently [1,2]. In a landmark study
in 2006, Redon and colleagues found that 1,447 CNV
regions cover at least 12% of the human genome, with no
large stretches exempt from CNV [3]. The CNV regions
cover more nucleotide content per genome than single
nucleotide polymorphisms (SNPs), suggesting the impor-
tance of CNV in genetic diversity [3]. A common way to
detect CNV is to utilize microarray-based methods [4].
The most commonly used method, array comparative
genomic hybridization (aCGH) was first used to detect
CNV a decade ago [5,6].
Microarray-based methods have revolutionized the way of
how large-scale genome studies are carried out. Today, the
next-generation sequencing technologies are transform-
ing biology research [7]. The rapid development of new
sequencing technologies is continuously increasing the
speed of sequencing and decreasing the cost. The next-
generation sequencing, such as 454 [8], Solexa [9] and
SOLiD [10] have already showed advantages over micro-
arrays in several aspects. Apart from being rapid and
cheap, data produced by sequencing can be re-used for
varied purposes as opposed to data from microarray-
based methods that can usually solely be used by one spe-
cific study. In addition, reproducibility has been one of
the major challenges for microarray technology [11]. The
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once revolutionizing microarray-based ChIP-Chip tech-
nology is being replaced by ChIP-Seq, in which the DNA
fragments are sequenced instead of being hybridized to an
array [12]. Sequencing-based methods are also used to
produce genome-wide DNA methylation profiles, detect
SNP, study chromosome translocations and RNA tran-
scriptome profiling [13-20].
Variation in sequencing coverage in genome assemblies
has been used as an indicator for potential CNV between
an assembled genome and shotgun data from another
genome [21,22]. This is analogous to a comparison of
copy number between microarray probes and a single set
of DNA fragments. There are two major problems with
this kind of approach. Given a certain hybridization con-
dition, hybridization efficiency varies among microarray
probes. Likewise, given a certain alignment threshold,
sequencing errors in combination with differences
between genomes may result in erroneous distribution of
the reads.
Secondly, the number of probes on a microarray does not
represent the real copy number of probe sequences in a
genome. Likewise, the copy number of DNA segments in
an assembled genome may not represent the true one.
Notably, the regions containing multiple copies are the
most difficult to assemble correctly and is still the key
unsolved problem in shotgun assembly [23]. Assembly
errors like these cause false variation in the sequencing
coverage and thus yield erroneous indication of CNV.
In this paper we describe an efficient solution based on a
robust model that combines the advantages of aCGH and
high-throughput sequencing. We also assessed CNV
between two individuals (Dr. J. Craig Venter [24], Dr.
James Watson [21]). An implementation of our method is
freely available at http://tiger.dbs.nus.edu.sg/CNV-seq.
Results and discussion
The Model
We have developed a method to detect CNV by shotgun
sequencing, CNV-seq. The method is based on a robust
statistical model that allows confidence assessment of
observed copy number ratios and is conceptually derived
from aCGH (Figure 1). The microarray-based procedure,
aCGH involves a whole genome microarray where two
sets of labeled genomic fragments are hybridized. Instead
of a microarray, CNV-seq uses a sequence as a template
and two sets of shotgun reads, one set from each target
individual, X and Y (Figure 1). The two sets of shotgun
reads are mapped by sequence alignment on a template
genome. We use a sliding window approach to analyze
the mapped regions and CNVs are detected by computing
the number of reads for each individual in each of the
windows, yielding ratios. These observed ratios are
assessed by the computation of a probability of a random
occurrence, given no copy number variation.
The random sampling in shotgun sequencing results in
uneven coverage that may lead to observed coverage ratios
that falsely imply CNV. Therefore, a statistical model is
essential for the assessment of the probability of false pos-
itive ratios. The average number of reads in a region of a
genome is dependent on the total number of reads sam-
pled, the length of the genome and the length of the
region. We use this relationship to compute a minimum
sliding window size to achieve a desired minimum confi-
dence level of the observations.
The mean number of reads for X and Y genomes in a slid-
ing window determines the distribution of the ratios. The
number of reads in a window is approximately distributed
according to Poisson, Po( ), where the mean number of
reads per window is , given by
where N is the total number of sequenced reads, G is the
size of the genome and W is the size of the sliding win-
dow, and W < <G. We use the Gaussian distribution to
approximate the Poisson distribution with mean and var-
iance  =  = 2. This approximation is good when the mean
number of reads per window is greater than 10 with con-
tinuity correction.
The predicted copy number ratio, r in each sliding win-
dow can be computed by
where z is the ratio of read counts in the window and NX
and NY are the total number of reads in the genomes X and
Y respectively. Assuming an independent distribution of
the read counts, we can obtain a probability, p of a copy
number ratio being r or divergent from 1:1 ratio by a ran-
dom chance. For this purpose, we need the distribution of
the read count ratio z. This distribution is given by Gaus-
sian ratio distribution [25]. The computation of this dis-
tribution is cumbersome, but it can be transformed to
another variable, t, by Geary-Hinkley transformation [26]:
where X, , Y and  are the means and the variances
for X and Y respectively. The new variable t approximately
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number of reads per window is greater than 6 in Y and less
than 40,000 in X. The p-value can be computed by
where Φ (t) is the cumulative standard Gaussian distribu-
tion function. The probability p decreases with increasing
sliding window size (Figure 2) and we would like p to be
as low as possible. Conversely, increased sliding window
size leads to a decreased resolution of CNV regions. There-
fore it is advantageous to compute a window size, which
yields the best possible resolution according to a preset
threshold of p for r. Based on the above equations, We can
calculate the best possible resolution, or the theoretical






























A comparison of the conceptual steps in aCGH and CNV-seq methodsFigure 1
A comparison of the conceptual steps in aCGH and CNV-seq methods. 1. Starting material in both cases is genomic 
fragments from two genomes. 2. In CNV-seq the fragments are samples and sequenced. 3. Genomic fragments are directly 
hybridized on to an array. In CNV-seq the mapping is performed by sequence alignment. 4. In microarray the light intensities 
reflect the number of hybridized fragments. In CNV-seq the number of mapped reads are counted directly. 5. Data analysis, 
including estimation of copy number ratios, confidence values, etc. 6. Output of the results.
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where p' is the desired significance level, and r' is the CNV
detection threshold ratio. Φ-1 is the inverse function of Φ.
The number of reads sampled will affect the minimum
window size. For example, if one wants to detect CNV
with ratio ≥ 3 : 2 at significance level 0.002, a genome size
of 3 G bases and 10 M reads in both genomes will yield
the minimum window size of 37,243 bases, while 1 M
reads will yield the window size of 372,431 bases. The use
larger number of reads allows detection of ten times
shorter CNV.
An alternative approach is to calculate the range of copy
number ratios that can be detected at a certain significance




In order to assess the performance of CNV-seq, we used
simulated and real human data. For the simulation of
shotgun data, in total of 101 genomes were constructed,
containing varied number, sizes and locations of CNV
regions, SNP and short insertions/deletions (indels). We
simulated three sequencing methods, Solexa, 454 and
Sanger [27] for each constructed genome on 0.1× to 8×
coverage. This resulted in the total of 8,400 simulations.
The Figure 3 shows the results of the simulations on var-
ied coverage and varied p' for constant log2(r') = 0.6. Each
dot represents an average of 100 simulations and the sizes
of the dots reflect the sizes of the lengths of the sliding
windows that are the theoretical minimum lengths, given
by equation (5). The overall specificity for our method is
between 91.7 – 99.9%, the sensitivity between 72.2 –
96.5% with the median of 99.4% and 89.9% respectively.
The mean sequence length is dependent on the technol-
ogy simulated. Thus, in order to reach the same coverage,
a larger number of fragments need to be sequenced when
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Dependencies of p in CNV-seqFigure 2
Dependencies of p in CNV-seq. The relation of p and 
sliding window size is shown on 0.1× to 8× sequence cover-
age for log2(r') = 0.6 and average read length 250 bases. The 
values are computed using equation (5). Increased window 
length results in decreased probability, p of observing ratio r' 
or higher by cheer chance. It is possible to compensate lack 


















Performance of CNV-seqFigure 3
Performance of CNV-seq. The performance of CNV-seq 
on data simulating 454, Sanger and Solexa methods. Results 
are shown for 0.1×–8× coverages (right) and p-value range of 
10-5-10-2 (top). Each dot represents an average of 100 simula-
tions and the size of the dots represents the window (log10) 
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short reads compared to the Sanger and 454 methods.
According to our model, the largest number of sequenced
reads yields the shortest length of the sliding window and
thus the best resolution. The range of window sizes in our
simulations varies from 1,103 bases to 2,951,792 bases,
decreasing with increasing average sequencing coverage.
The results show that our model performs well in the pres-
ence of errors. Despite of increased resolution due to
shortening of the sliding window size, the sensitivity is
increased together with increased sequencing coverage.
Slight drop in specificity with increasing sequencing cov-
erage can be observed (Figure 3). This is likely to be due
to SNPs, short indels, and read mapping errors, that are
not considered in our statistical model and have a more
profound effect on small windows. The specificity does
not drop in error free data. The effect of errors may be
reduced by using a window size that is larger than the the-
oretical minimum. For example, the theoretical minimum
window for 8× Solexa sequencing at p = 0.001 is 1947
bases. This window size gives a specificity of 95.4%, while
a 2 times larger window yields specificity of 97.8% (Figure
4).
Analysis of human data
The genomes of two individuals, Dr. Craig J. Venter and
Dr. J. Watson were recently sequenced on 7.5× and 7.4×
coverage respectively [21,24]. The genome of Dr. Craig J.
Venter is sequenced using Sanger method and Dr. J.
Watson's genome using 454 technology. We compared
the two genomes using CNV-seq (Figure 5 and Additional
File 1). The thresholds p' = 10-5 and log2(r') = 0.6 yield
sliding window size of 26,481 bases for autosomal chro-
mosomes. The sex chromosomes have a lower sequencing
coverage than autosomal chromosomes, therefore larger
window sizes are used: 72,044 bases for chromosome X
and 269,032 bases for chromosome Y. We identified 174
contiguous regions covered by four or more consecutive
windows. The sizes of these regions range from 66,202
bases to 941,612 bases.
The comparison of the 174 CNV calls with those in the
Database of Genomic Variants (DGV) [2] revealed 142 of
the CNV calls to overlap more than 50% with previously
reported CNV regions. In order to asses the significance of
CNV calls, we performed 5,000 permutation tests, using
174 randomly distributed CNV regions of the same sizes
as in the original experiment. In average, only 56 and
maximum 78 of 174 regions overlap more than 50% with
CNV in DGV (Figure 6) 5,000 random sets. The real CNV
calls have significantly larger overlap with DGV (p = 0).
We also intersected the CNV calls with the CNVs identi-
fied by aCGH in the two genomes. There are 23 and 45
CNV regions reported in Watson's and Venter's genome
respectively [21,24]. We found 15 of our CNV calls over-
lap with 10 of previously reported Watson's CNV regions,
and only 11 of our CNV calls overlap with 5 of Venter's.
The low overlap with Venter's CNV calls made by aCGH is
not surprising, for the reason that the majority of the CNV
regions were detected by only one of three microarray
platforms [24]. There are 121 CNV calls that made by
CNV-seq but not aCGH and overlap with DGV data, sug-
gesting that CNV-seq can detect CNV regions that were
missed by aCGH. One of these regions is shown in Figure
5 (bottom panel), a 238 kb region (copy number ratio
6:1, p = 0) containing two genes (FAM23B, MRC1L1) and
one miRNA (hsa-mir-511-2). We have used stringent
thresholds in our analysis, thus by lowering thresholds,
such as p-value and the number of consecutive windows,
will increase the number of reported CNV calls.
A major assumption in CNV-seq is that shotgun sampling
of DNA fragments is random, and therefore the CNV calls
made by CNV-seq are not due to different sequencing bias
between the two sets of data compared. When the two sets
of data are prepared in the same way, this assumption is
valid. However, when the shotgun sequences are gener-
ated using two different sequencing methods, the assump-
tion may not hold any more. Solexa sequencing reads are
recently reported to be GC-biased dependent on a library
preparation procedure [28]. Venter's genome was
sequenced using 454 and Watson's genome was
sequenced using the Sanger method. We compared the
Specificity vs window sizeFigure 4
Specificity vs window size. In order to increase specificity, 
a larger than the theoretical minimum window size can be 
used by sacrificing resolution. The specificities using 1×, 1.5×, 
2×, 3×, 4×, and 5× of the theoretical minimum window size 
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distribution of GC frequencies in the shotgun reads in
both genomes. There are no significant differences
between the two distributions (p = 0.2106, Kolmogorov-
Smimrov test).
Conclusion
We have developed a method to detect CNV using shot-
gun data. Our approach not only combines the advan-
tages of microarray methods and high-throughput
sequencing, but is also based on a robust statistical model
allowing confidence assessment. We tested the approach
on both simulated and real data and the results show that
the method can be applied to relatively low sequencing
coverage with good specificity and sensitivity. We have
also developed a model to compute the theoretical limit
of resolution for given data at a desired confidence level.
We expect the continued rapid development of sequenc-
ing technologies to further lower the cost and increase the
speed of sequencing. Thus, sequencing-based approaches
are likely to gain increased advantage over microarrays.
Next-generation sequencing methods mostly produce a
large number of short reads and our results show that the
number of reads sequenced – not the length of the reads,
is the most important factor that determines the resolu-
tion, i.e. larger number of sequenced fragments results in
increased resolution. Alternatively, given a constant reso-
lution an increase in the number of sequenced reads will
result in increased sensitivity and specificity. Therefore, a
large number of short reads is an advantage as opposed to
a small number of long reads.
Methods
Simulations
The human chromosome 1 (NCBI build 36) was used to
construct one diploid reference genome and 100 diploid
test genomes. The unmodified chromosome 1 sequence
was used as the template genome. The test individual
Copy number variation between two human individualsFigure 5
Copy number variation between two human individuals. Copy number variation detected by CNV-seq using shotgun 
sequence data from two individuals, Venter and Watson. The top panel shows a genome level log2 ratio plot. The middle panel 
shows the plot for chromosome 10. The bottom panel shows detailed view of a CNV region in chromosome 10. The red color 
gradient in the middle and bottom sections represents log10 p calculated on each of ratios.
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genomes are constructed by the introducing CNV, SNPs
and short indels. The CNV is introduced into each of the
test genomes by concatenating the two chromosomes and
by selecting nine source sequences at random positions to
replace 26 target sequences at random positions. Four of
the nine source sequences are used four times each to
replace four random target sequences and the remaining
five of the nine sequences are used to replace two random
target sequences each. The procedure results in the total of
35 segments in each of the 100 simulated test genomes
with the following copy number ratios: 26 with ratio 1:2,
five with ratio 4:2 and four with ratio 6:2. The length of
the source sequences is 10k, where k is a random number
between log10 500 and log10 2 M, yielding the median
length of 26,464 bases and the mean 234,065.7 bases. In
addition, each test genome is modified by randomly
introducing 5 SNPs/kb and short, 1–3 bp insertions/dele-
tions with the frequency of 0.5 indels/kb.
The reference genome is constructed the same way as the
individual test genomes, except no CNV was introduced.
We simulated the shotgun sequencing process for test and
reference genomes by using real sequence quality files,
specific for each sequencing method. The quality files
used for Sanger and 454 sequencing were downloaded
from the personal genome projects of Venter [24] and
Watson [21] in Trace Archive [29], respectively. For the
simulation of Solexa method we used quality files from
the project SRA000261 in Trace Archive. The lengths of
the quality files define the read lengths at a random start-
ing position. The errors were introduced according to
quality values given in the quality files. Both Sanger and
454 methods use Phred quality values [30], q and the
error probabilities, e are given by e = 10q/-10. The errors are
introduced by generating a random number R between 0
and 1. If R <e, then one of the following errors will be
introduced: Substitution to one of the three remaining
bases, an insertion or a deletion. The probability of an
indel is 10% of all introduced errors with the equal ratio
of indels. The base frequency in the source genome is used
to calculate the frequency of each base, which is in turn
used to give the insertion and substitution probability.
The Solexa quality values, qs can be converted to Phred
quality scores as follows
We simulated the shotgun process for 0.1×, 0.2×, 0.5×, 1×,
2×, 5× and 8× coverages.
The performance is measured by counting the number of
sliding windows giving a correct alternatively an incorrect
prediction. Our model describes the theoretical limit of
detection for given data with given r' and p'. The true copy
number ratio of each window is known in the simulated
data, i.e. the true r. All windows where true r ≥ r' or r ≤ 1/
r' should be classified as CNV in order to achieve 100%
sensitivity. Similarly, all windows where true r ≤ r' or r ≥
1/r' should not be classified as CNV in order to achieve
100% specificity.
CNV detection in human data
The shotgun sequencing data were downloaded from the
personal genome projects of Venter and Watson in Trace
Archive. The template genome was downloaded from
Ensembl [31], human genome assembly, NCBI Build 36.
The thresholds p' = 10-5 and log2(r') = 0.6 are used. Given
the data these thresholds yield the window size, W = 26,
481 bases for autosomal chromosomes, 72,044 bases for
chromosome X and 269,032 bases for chromosome Y.
CNV-seq
All calculations are performed using R [32] and sequences
aligned by BLAT [33]. The whole procedure is automated
by Perl http://www.perl.org scripts.
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Permutation test of CNV callsFigure 6
Permutation test of CNV calls. A permutation test was 
performed in order to test the significance of our CNV calls. 
The histogram shows the number of CNV calls overlapping 
with CNV in DGV. The X-axis shows the number of calls 
overlapping with DGV. The Y-axis shows the frequency of 
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